Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1050.Time spend outdoors in summer,46583,0.00857408069573889,0.0216293023662409,-0.0338193519420933,0.0509675133335711,0.691804101452105
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1060.Time spent outdoors in winter,40625,0.0434113804235181,0.0244216948738245,-0.00445514152917784,0.0912779023762141,0.0754812578026001
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X1070.Time spent watching television (TV),48989,-0.0743953745122482,0.0216946614712828,-0.116916910995963,-0.0318738380285339,0.000605857341444448
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X1080.Time spent using computer,40648,0.052272904078973,0.0224798550553331,0.00821238817052009,0.0963334199874258,0.0200596407249922
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X1090.Time spent driving,35264,-0.0209507289269146,0.0244947173449013,-0.0689603749229211,0.0270589170690918,0.392381926725963
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1160.Sleep duration,51625,-0.0133016494359742,0.0197747687350323,-0.0520601961566375,0.0254568972846892,0.501168128685443
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,17276,0.0275884125847752,0.0102885790654018,0.00742279761658769,0.0477540275529627,0.00733713869715994
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,17276,-0.028529882955779,0.0100151106656955,-0.0481594998605423,-0.00890026605101576,0.00439523950212333
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,17276,-0.0152378533857823,0.0114181038562865,-0.0376173369441039,0.00714163017253919,0.182046354424258
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,17276,-0.0210245163865067,0.0116901029938939,-0.0439371182545388,0.00188808548152531,0.0721170849611507
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,17276,-0.0191945690118261,0.0118941666501994,-0.0425071356462169,0.00411799762256468,0.10659341869998
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,17276,-0.0244039982543203,0.0252556549641291,-0.0739050819840133,0.0250970854753727,0.333918341646936
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,17276,-0.0652360016781193,0.0263138113053724,-0.116811071836649,-0.0136609315195893,0.0131789029599363
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,17276,-0.00887544795543648,0.0179933806639603,-0.0441424740567986,0.0263915781459257,0.62183386660812
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,17276,-0.0353165693293104,0.013229435765129,-0.0612462634289632,-0.00938687522965764,0.00760252523458929
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,17276,-0.0207613449143085,0.00904014467462807,-0.0384800284765795,-0.00304266135203751,0.0216551035605116
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#18.Location of pain during the past week_Upper back,17276,-0.0167936572011951,0.0130681975389879,-0.0424073243776113,0.00882000997522108,0.198782162457194
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#19.Location of pain during the past week_Lower back,17276,-0.020306461806027,0.00733806155202646,-0.0346890624479989,-0.00592386116405515,0.00565865837171769
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,17276,-0.00316971482422722,0.00948138363132591,-0.021753226741626,0.0154137970931716,0.7381502268885
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,17276,-0.0415804186457142,0.014079301713463,-0.0691758500041017,-0.0139849872873266,0.00314818727902206
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,17276,-0.0174171059188766,0.0132514719655328,-0.0433899909713209,0.00855577913356767,0.188745055551948
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,17276,-0.0111499161796889,0.0176756979023703,-0.0457942840683347,0.0234944517089568,0.528176475136557
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,17276,0.00642929289853159,0.0167210621797413,-0.0263439889737614,0.0392025747708246,0.70061066076949
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#7.Location of pain during the past week_Left hip,17276,-0.0256252492827626,0.0102790595183168,-0.0457722059386635,-0.0054782926268616,0.0126777280894846
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#8.Location of pain during the past week_Right hip,17276,-0.017911572126988,0.00975565183540333,-0.0370326497243785,0.00120950547040257,0.066371884086913
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,17276,-0.013684559109421,0.0121851315748375,-0.0375674169961024,0.0101982987772605,0.261430237390818
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120040.Fatigue severity over the past week,17288,-0.077689437550364,0.0356007480526058,-0.147466903733471,-0.00791197136725671,0.0291051243178268
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120041.Waking unrefreshed severity over the past week,17288,-0.0627968799599236,0.0353137478083595,-0.132011825664308,0.00641806574446099,0.0753794248094035
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120042.Cognitive symptoms severity over the past week,17288,-0.0493168193974481,0.0381376736273122,-0.12406665970698,0.0254330209120838,0.195984760775404
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120098.Mobility problems today,17297,-0.110136297963066,0.0415408249387486,-0.191556314843013,-0.0287162810831187,0.00802608210444074
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120099.Self-care problems today,17297,-0.309616876623722,0.0641075596817443,-0.435267693599941,-0.183966059647503,1.37946813421087e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120100.Problems doing usual activities,17297,-0.11543612548616,0.0397434825759462,-0.193333351335014,-0.0375388996373053,0.00368271359950074
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120101.Pain or discomfort today,17297,-0.0652607038899887,0.0355749055789352,-0.134987518824702,0.00446611104472439,0.0666030792995448
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120102.Anxiety or depression today,17297,-0.0290125141582329,0.0430583506983556,-0.11340688152701,0.0553818532105441,0.500450478210156
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120103.Scale to indicate how health is today,17240,0.00758461731557678,0.00318357147801447,0.00134481721866842,0.0138244174124851,0.0172098619502749
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,17256,-0.0581010444393066,0.0433454507173966,-0.143058127845404,0.0268560389667906,0.180126984786111
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",17231,-0.0709490821599572,0.0445895863604455,-0.15834467142643,0.0164465071065161,0.111592357998123
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",17267,-0.0575003816939025,0.0353499876126423,-0.126786357414681,0.0117855940268764,0.103839791584519
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,17266,-0.105359193583733,0.0361780705953367,-0.176268211950593,-0.034450175216873,0.00359307679404753
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,17274,-0.0443578657758685,0.0466431401675273,-0.135778420504222,0.0470626889524851,0.341615087488346
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120109.Feeling bad about self over the last two weeks,17226,-0.0133685397258694,0.0468022970879319,-0.105101042018216,0.0783639625664771,0.775158421015359
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120110.Trouble concentrating over the last two weeks,17272,-0.0529893072638033,0.046812123613633,-0.144741069546524,0.0387624550189174,0.257668275983427
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,17255,-0.21578736086822,0.0679594844132389,-0.348987950318168,-0.0825867714182718,0.00149978431497024
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,17183,-0.0359429590674541,0.0928354703229736,-0.217900480900482,0.146014562765574,0.698636353453517
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",12039,-0.107297805135523,0.0478527186156906,-0.201089133622276,-0.0135064766487691,0.024963311129849
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46706,-0.0629270586046063,0.0483367861333401,-0.157667159425953,0.0318130422167403,0.19297540884825
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,43585,-0.0637609282575247,0.0295936728432992,-0.121764527030391,-0.00575732948465834,0.0312028454275223
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1289.Cooked vegetable intake,50127,-0.0929175674308993,0.0206884114938327,-0.133466853958811,-0.0523682809029872,7.09523377592602e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1299.Salad  or  raw vegetable intake,48768,-0.0278404291399548,0.0218378318599594,-0.0706425795854752,0.0149617213055655,0.202360808934183
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1309.Fresh fruit intake,50031,-0.0196491576339017,0.0216580069338342,-0.0620988512242168,0.0228005359564134,0.364280667464257
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1319.Dried fruit intake,47249,0.00377266871723288,0.0223229745562972,-0.0399803614131095,0.0475256988475753,0.865794334185509
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X134.Number of self-reported cancers,52067,-0.03194161976568,0.0385715828528055,-0.107541922157179,0.0436586826258187,0.407610443221431
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X135.Number of self-reported non-cancer illnesses,52068,-0.262517858276477,0.0207037091386781,-0.303097128188286,-0.221938588364668,8.68088089680078e-37
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X136.Number of operations, self-reported",52068,0.0271626024130246,0.02030673453665,-0.0126385972788093,0.0669638021048585,0.181027660594704
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X137.Number of treatments or medications taken,52068,-0.347390921928563,0.0203045895342771,-0.387187917415746,-0.30759392644138,1.92195739161319e-65
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1438.Bread intake,50548,0.00424727840919324,0.00193181544065135,0.000460920145516589,0.00803363667286989,0.0279112989002709
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1458.Cereal intake,49427,-0.0316584490424884,0.0206061037356972,-0.0720464123644548,0.00872951427947803,0.12445585400403
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1488.Tea intake,50255,-0.00980293888253179,0.00184803495529244,-0.013425087394905,-0.00618079037015861,1.13446787743551e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1498.Coffee intake,47982,-0.187532189815884,0.0207610788021377,-0.228223904268074,-0.146840475363694,1.73266206575398e-19
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1528.Water intake,48128,0.0344201574205939,0.0209429212190043,-0.00662796816865452,0.0754682830098422,0.100281455569517
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1568.Average weekly red wine intake,35434,0.0391259489913467,0.0240036625456821,-0.00792122959819011,0.0861731275808836,0.103110573621432
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,35424,0.0770099753987892,0.0246183961562576,0.0287579189325244,0.125262031865054,0.00176054457196904
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1588.Average weekly beer plus cider intake,35525,0.0643921643590204,0.0273088891195996,0.0108667416846051,0.117917587033436,0.0183830648656241
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1598.Average weekly spirits intake,35382,-0.0494022972810703,0.0264726420386768,-0.101288675676877,0.00248408111473623,0.0620266643180417
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1608.Average weekly fortified wine intake,35498,0.0255041317503417,0.0437790343453385,-0.0603027755665218,0.111311039067205,0.560189895810568
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1737.Childhood sunburn occasions,39069,0.0103185513199328,0.0244623546785369,-0.0376276638499996,0.0582647664898652,0.673163476601159
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1807.Father's age at death,38347,0.00632145601226777,0.00213632092289644,0.00213426700339073,0.0105086450211448,0.00308789042862955
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1845.Mother's age,19822,0.00356352252973056,0.00482650627191536,-0.00589642976322355,0.0130234748226847,0.460326696299813
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1873.Number of full brothers,51129,0.0179786310292433,0.0198937025799389,-0.0210130260274369,0.0569702880859234,0.366140308503242
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1883.Number of full sisters,51139,-0.0324274551842662,0.0199207712776533,-0.0714721668884667,0.00661725651993428,0.103568951415316
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20015.Sitting height,51661,0.0294152206413683,0.0024318316974513,0.0246488305143637,0.0341816107683728,1.23272564525248e-33
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20016.Fluid intelligence score,16692,0.131349584347327,0.0326000380017771,0.0674535098638442,0.19524565883081,5.62335898828954e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20018.Prospective memory result,17388,-0.135536682529293,0.0429102738636232,-0.219640819301994,-0.0514325457565912,0.00158796706523154
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),16476,-0.00753654428498109,0.00339876214347698,-0.014198118086196,-0.000874970483766204,0.0266067801893886
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),16455,-0.0109335055463416,0.00338922172176995,-0.0175763801210107,-0.0042906309716725,0.00125794958086951
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20023.Mean time to correctly identify matches,51439,-0.00612151109655168,0.00195796666943319,-0.00995912576864074,-0.00228389642446263,0.00177021088639144
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#1.Illnesses of father_Heart disease,45282,-0.00351068274706926,0.00415084598215338,-0.0116463408720899,0.00462497537795137,0.39768261235903
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,44390,0.0107545117429915,0.00913907636950574,-0.00715807794123972,0.0286671014272228,0.23929708966207
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,44318,0.000320022902810312,0.0122718281575467,-0.0237327602859813,0.0243728060916019,0.979195361065927
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#12.Illnesses of father_Severe depression,44358,0.0155717230178725,0.0103572626505559,-0.00472851177721703,0.035871957812962,0.132727762086238
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,44384,-0.000411092753278319,0.00738905979992085,-0.0148936499611232,0.0140714644545665,0.955632572231553
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#2.Illnesses of father_Stroke,44726,0.00248306447198638,0.00534798266444639,-0.00799898155032855,0.0129651104943013,0.64243560418596
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#3.Illnesses of father_Lung cancer,44605,-0.00653386916119301,0.00675594785539469,-0.0197755269577666,0.00670778863538058,0.33348508602401
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,44408,0.0010516600810069,0.00842584508241563,-0.0154629962805277,0.0175663164425415,0.90067168329366
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,44687,-0.0120289395979794,0.0061837476876385,-0.0241490850657509,9.12058697920531e-05,0.0517510759216795
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#8.Illnesses of father_High blood pressure,44839,0.003643217778872,0.00464658951628364,-0.00546409767304394,0.0127505332307879,0.433007431251848
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#9.Illnesses of father_Diabetes,44560,-0.0123677467907551,0.00644257064207265,-0.0249951852492175,0.000259691667707307,0.0549032839379266
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#1.Illnesses of mother_Heart disease,47486,-0.00195925129594738,0.00476446649966402,-0.0112976056352889,0.0073791030433941,0.68091194460885
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,47189,0.00738729127912698,0.00683554864468215,-0.00601038406445004,0.020784966622704,0.279828696071741
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,47041,0.0206787286278156,0.0149110350798669,-0.00854690012872351,0.0499043573843546,0.165507178960362
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#12.Illnesses of mother_Severe depression,47115,-0.0156848985086481,0.00765727360792652,-0.030693154780184,-0.000676642237112075,0.0405296866242339
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#2.Illnesses of mother_Stroke,47363,-0.000219598224177818,0.00542500234688461,-0.0108526028240716,0.010413406375716,0.967711485073586
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,47143,0.00799114992837946,0.00958868272944817,-0.0108026682213389,0.0267849680780979,0.40462682370823
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,47105,0.00225640989483672,0.00860361117203849,-0.0146066680023587,0.0191194877920322,0.793119741556491
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,47141,0.00543690944720656,0.00699369310760909,-0.00827072904370726,0.0191445479381204,0.436925666884007
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,47194,0.0132693968349142,0.00805044970777513,-0.00250948459232502,0.0290482782621535,0.0993018448232376
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,47565,0.00521087464802734,0.00412365276639087,-0.00287148477409876,0.0132932340701534,0.206360059991308
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#9.Illnesses of mother_Diabetes,47261,-0.0140502460269452,0.00635771907091272,-0.0265113754059341,-0.00158911664795624,0.0271133562871611
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,40720,-0.0281521943467311,0.00670425092041537,-0.0412925261507452,-0.015011862542717,2.68480842292439e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,40425,0.0180176450953052,0.0266614320339438,-0.0342387616912247,0.070274051881835,0.499175090435021
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,40415,0.0515326638661681,0.0269865090731356,-0.00136089391717763,0.104426221649514,0.0561955052717733
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,40536,-0.00387001597575192,0.00788888393597389,-0.0193322284902607,0.0115921965387569,0.623736297863046
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,40446,0.0121526805756852,0.0156903640564584,-0.0186004329749731,0.0429057941263436,0.438621100763256
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#2.Illnesses of siblings_Stroke,40495,-0.0417115566890407,0.0113289108696746,-0.063916221993603,-0.0195068913844784,0.000231831883254208
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,40447,-0.0336854730253777,0.013392182904736,-0.0599341515186602,-0.0074367945320951,0.0118966672639364
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,40449,-0.0086740411099536,0.013023717282383,-0.0342005269834243,0.0168524447635171,0.505402856201586
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,40475,0.0130306045536845,0.00987227218611642,-0.00631904893110364,0.0323802580384727,0.186869364234568
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,40494,-0.00397743273903779,0.0121485962454223,-0.0277886813800655,0.0198338159019899,0.743368159536716
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,40859,-0.000570445599971174,0.00500280671423266,-0.0103759467598672,0.00923505555992483,0.909218446564133
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,40638,-0.0346960230822864,0.00709527975565663,-0.0486027714033734,-0.0207892747611994,1.01212985242149e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20127.Neuroticism score,41402,-0.0296794194999061,0.0208179539071199,-0.0704826091578612,0.011123770158049,0.153972729139595
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,16692,0.065919681859375,0.0331309288473004,0.000983061318666226,0.130856302400084,0.046643391361748
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X20161.Pack years of smoking,15856,-0.026031334205688,0.00361302662532506,-0.0331128663913252,-0.0189498020200509,6.07224441777302e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,15856,-0.0260213035022712,0.00356362135205948,-0.0330060013523078,-0.0190366056522346,2.97155845305869e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20191.Fluid intelligence score,12849,0.140106132717152,0.0379588178408365,0.0657068497491124,0.214505415685191,0.000224296494767092
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,12850,0.0859873986162736,0.0386878106323891,0.010159289776791,0.161815507455756,0.0262603815545449
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20240.Maximum digits remembered correctly,11541,0.0647331762254587,0.0404538626283445,-0.0145563945260966,0.144022746977014,0.109587647595414
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20255.Spirometry QC measure,38728,-0.019483983792893,0.0267086084928759,-0.0718328564389299,0.0328648888531438,0.465699047119217
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X20261.avMSE,11392,-0.0065168581749292,0.00402883390454496,-0.0144133726278373,0.00137965627797892,0.105786374136977
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X20262.Myopia diagnosis,11392,0.0420490926071061,0.0495655699600425,-0.0550994245145772,0.139197609728789,0.396259340143612
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X20280.Glucose-lactate,29714,-0.0116311643882066,0.00246698509219208,-0.0164664551689031,-0.00679587360751013,2.43131210127604e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X20281.Spectrometer-corrected alanine,29776,0.00869640281079358,0.00247444069131829,0.00384649905580974,0.0135463065657774,0.000441249582758463
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,16263,-0.00604123604018973,0.0130017700461815,-0.0315247053307055,0.0194422332503261,0.642190351452482
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,16260,0.0294420192100139,0.0255985138583397,-0.0207310679523319,0.0796151063723597,0.250100819125182
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),16258,-0.0136035121912487,0.0316051456219567,-0.0755495976102838,0.0483425732277863,0.666895274904371
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),16258,0.000845245422172369,0.0123359724985206,-0.023333260674928,0.0250237515192728,0.945373537737359
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),16258,0.000358918803577349,0.0214430563894971,-0.041669471719837,0.0423873093269917,0.98664565409484
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,16268,-0.0138040165657002,0.0274290753798744,-0.0675650043102541,0.0399569711788537,0.614786764911335
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,16268,-0.00502203958210699,0.0178090146408184,-0.039927708278111,0.0298836291138971,0.777951515741226
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,16268,0.00570943836189108,0.0199585340508241,-0.0334092883777241,0.0448281651015062,0.774831971197259
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,16268,0.00647092955461103,0.0310583588449008,-0.0544034537813946,0.0673453128906166,0.834960303100727
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,16268,0.0316943588375632,0.0360204373091995,-0.0389056982884678,0.102294415963594,0.378926853689684
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,16268,-0.0173059762733374,0.020777823295203,-0.0580305099319353,0.0234185573852605,0.404909913435493
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,16268,0.0603325910181858,0.0356267586414303,-0.00949585591901748,0.130161037955389,0.0903865680308085
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,16268,-0.0184948055729949,0.026478146502032,-0.0703919727169776,0.0334023615709877,0.484878795262536
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),16270,-0.0395650283605946,0.0359945674554943,-0.110114380573364,0.0309843238521743,0.271699542594298
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),16270,-0.0146244975828232,0.0165511756325443,-0.04706480182261,0.0178158066569635,0.376929200663157
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),16270,0.0179350901241916,0.0248057605138121,-0.0306842004828801,0.0665543807312634,0.469677276985767
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,16272,0.0212577397262804,0.0411874337922406,-0.0594696305065112,0.101985109959072,0.605776239036931
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20600.Liking for adding salt to foods,18830,0.0674447207150977,0.0314654107555855,0.00577251563415021,0.129116925796045,0.032089295141999
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20601.Liking for aniseed,18830,-0.00745134025510841,0.0312832846011626,-0.0687665780733872,0.0538638975631704,0.81173695506062
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20602.Liking for apple juice,18830,0.0295028894680161,0.0314594322459011,-0.0321575977339501,0.0911633766699824,0.348355422258157
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20603.Liking for apples,18830,-0.0189707672453065,0.0321007381615759,-0.0818882140419953,0.0439466795513823,0.554543574382607
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20604.Liking for asparagus,18830,-0.00044541310192719,0.0318279125855732,-0.0628281217696506,0.0619372955657962,0.988834583106258
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20605.Liking for aubergine,18830,-0.0098365227280408,0.0313985788507094,-0.0713777372754313,0.0517046918193497,0.754071999641171
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20606.Liking for avocados,18830,0.0177992197878071,0.0318621963182366,-0.0446506849959367,0.0802491245715508,0.576420032580758
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20607.Liking for bacon,18830,-0.0310318769856793,0.0317613186916015,-0.0932840616212182,0.0312203076498597,0.328565062836167
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20608.Liking for baked or steamed fish,18830,-0.133016110806016,0.0319274073965381,-0.19559382930323,-0.0704383923088009,3.11095514866213e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20609.Liking for bananas,18830,-0.0480124243598721,0.0325664438993525,-0.111842654402603,0.0158178056828588,0.140419919236416
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20610.Liking for barbequed or grilled meat,18830,-0.0555073086323958,0.0315416341303196,-0.117328911527822,0.00631429426303057,0.0784561453238572
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20611.Liking for beef steak,18830,-0.0649596375403097,0.0317258918537411,-0.127142385573642,-0.00277688950697716,0.0406201763751207
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20612.Liking for beetroot,18830,-0.0626374767582821,0.0319749774087146,-0.125308432479363,3.34789627984e-05,0.0501330495989415
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20613.Liking for bell pepper,18830,-0.0324561434431307,0.0315514961246865,-0.0942970758475161,0.0293847889612548,0.303647018881898
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20614.Liking for bicycling,18830,0.152321359495516,0.0313858608276269,0.0908050722733667,0.213837646717664,1.22468750531596e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20615.Liking for biscuits,18830,0.0419058236635929,0.0314521834261464,-0.0197404558516541,0.10355210317884,0.182756052147484
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20616.Liking for bitter foods,18830,-0.0191393812967297,0.0314155780117828,-0.080713914199824,0.0424351516063647,0.542377907762357
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20617.Liking for bitter or ale,18830,0.0720886090319741,0.0320467333716075,0.00927701162362342,0.134900206440325,0.0244932468336097
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20618.Liking for black olives,18830,0.0243401050189228,0.0315821719534037,-0.0375609520097485,0.086241162047594,0.440899613950585
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20619.Liking for black pepper,18830,0.00448646599362077,0.0317994578120094,-0.0578404713179176,0.0668134033051592,0.887803323445698
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20620.Liking for blue cheese,18830,-0.0701033146240577,0.0316851837212306,-0.13220627471767,-0.00800035453044566,0.0269444397704432
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20621.Liking for bolognese sauce,18830,-0.0242562249170095,0.0318043554495239,-0.0865927615980762,0.0380803117640573,0.445669845163542
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20622.Liking for broad beans,18830,-0.0445496226852399,0.0313542365050533,-0.106003926235144,0.0169046808646645,0.155377360792976
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20623.Liking for broccoli,18830,-0.0332352241977777,0.032368739237122,-0.0966779531025368,0.0302075047069813,0.304542365373649
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20624.Liking for brown rice,18830,-0.0245228526710904,0.0314949496043862,-0.0862529538956874,0.0372072485535066,0.436208619237982
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20625.Liking for brussel sprouts,18830,-0.0923606532147957,0.0317088003396764,-0.154509901880561,-0.03021140454903,0.00358652097964373
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20626.Liking for burgers (meat),18830,-0.0559188683440553,0.0313016400468797,-0.11727008283594,0.00543234614782885,0.0740422526786216
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20627.Liking for burn of spicy foods,18830,-0.0244023791146598,0.0313470365138726,-0.0858425706818502,0.0370378124525306,0.436308329291954
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20628.Liking for butter on bread,18830,0.0136603679452351,0.0317660236575317,-0.048601038423527,0.0759217743139972,0.667178177908038
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20629.Liking for butternut squash,18830,0.0247049972750103,0.0314193088718395,-0.0368768481137951,0.0862868426638157,0.431701758047919
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20630.Liking for cabbage,18830,-0.0504840070548017,0.0318086130088915,-0.112828888552229,0.0118608744426257,0.112502841271987
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20631.Liking for cake,18830,0.01415724073233,0.031584690148513,-0.0477487519587555,0.0760632334234155,0.653991576056001
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20632.Liking for cake icing,18830,-0.00116605032343361,0.031227533637442,-0.0623720162528199,0.0600399156059527,0.970213945632499
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20633.Liking for capers,18830,0.00265917823276114,0.0313183979842596,-0.0587248818163878,0.06404323828191,0.932335544689998
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20634.Liking for cauliflower,18830,-0.117245923326963,0.0319701262433525,-0.179907370763934,-0.054584475889992,0.000245744334616481
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20635.Liking for cereal or granola bar,18830,0.0225339312124298,0.0312732797764503,-0.0387616971494129,0.0838295595742725,0.471195982596696
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20636.Liking for cheesecake,18830,-0.00720971486522924,0.0314160496713665,-0.0687851722211077,0.0543657424906492,0.818489459052125
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20637.Liking for cherries,18830,-0.0566788662691765,0.0329802151493487,-0.1213200879619,0.00796235542354694,0.0857088357651468
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20638.Liking for chicken,18830,-0.0706221985087463,0.0331582480120049,-0.135612364612276,-0.0056320324052167,0.0331966853900787
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20639.Liking for chilli pepper,18830,-0.000636323982466747,0.0315717784944381,-0.0625170098315655,0.061244361866632,0.983920070910767
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20640.Liking for chips or french fries,18830,0.0446409472024463,0.0316694485474203,-0.0174311719504974,0.10671306635539,0.158677230853711
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20641.Liking for cigarette smoking,18830,-0.0920700951864606,0.0504633938316677,-0.190978347096529,0.00683815672360807,0.0680934719687952
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20642.Liking for cod,18830,-0.135341830734797,0.0322821798242019,-0.198614903190233,-0.0720687582793617,2.77204400291556e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20643.Liking for coffee with sugar,18830,-0.000824790364355767,0.0342646019735934,-0.0679834102325987,0.0663338295038872,0.980796064655235
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20644.Liking for coffee without sugar,18830,-0.119445488174978,0.0321150447729922,-0.182390975930043,-0.0565000004199137,0.000200356158760479
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20645.Liking for coriander,18830,-0.0331693698881448,0.0314168936264418,-0.0947464813959707,0.0284077416196811,0.291081689667239
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20646.Liking for corn flakes,18830,-0.0334416597619841,0.0312634679618922,-0.0947180569672929,0.0278347374433246,0.284780652207504
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20647.Liking for cream,18830,0.0158465287487454,0.0312915100429389,-0.0454848309354148,0.0771778884329057,0.612570415199485
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20648.Liking for croissant,18830,0.0231160136506813,0.0314386267104459,-0.0385036947017926,0.0847357220031553,0.462181636972092
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20649.Liking for cucumber,18830,-0.0623244216071026,0.0315636858600318,-0.124189245892765,-0.000459597321440339,0.0483325991127451
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20650.Liking for curry,18830,-0.0589412135768634,0.0317566208672121,-0.121184190476599,0.0033017633228722,0.0634650356076082
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20651.Liking for dairy products,18830,-0.0261228608817502,0.0318296208686846,-0.088508917784372,0.0362631960208717,0.411822363533406
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20652.Liking for dark chocolate,18830,-0.102685412498181,0.0315443495425237,-0.164512337601527,-0.0408584873948341,0.001134844193032
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20653.Liking for diet fizzy drinks,18830,-0.0724076956377627,0.0324092972605978,-0.135929918268534,-0.00888547300699101,0.025483967442215
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20654.Liking for dried fruit,18830,-0.0442186974374895,0.0316188857646505,-0.106191713536204,0.0177543186612253,0.161982444656046
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20655.Liking for eggs,18830,-0.112727802103786,0.0323131821860401,-0.176061639188425,-0.0493939650191479,0.000486665323778816
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20656.Liking for exercising alone,18830,0.105369923000535,0.0314711988001299,0.04368637335228,0.167053472648789,0.000815160588894957
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20657.Liking for exercising with others,18830,0.125125638747513,0.0314317220336925,0.0635194635614757,0.18673181393355,6.89210270627414e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20658.Liking for extra virgin olive oil,18830,-0.00908948669643662,0.03182578528822,-0.0714680258613477,0.0532890524684745,0.775186627795866
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20659.Liking for fatty foods,18830,0.0543982843774642,0.0313053004875721,-0.00696010457817713,0.115756673333106,0.0822853306084283
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20660.Liking for fresh tomatoes,18830,-0.0945101974089817,0.0336473630589152,-0.160459029004455,-0.028561365813508,0.00497709872329477
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20661.Liking for fried chicken,18830,-0.0221046053717135,0.0312799727274405,-0.0834133519174969,0.03920414117407,0.479780589152639
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20662.Liking for fried or battered fish,18830,-0.0465670269283322,0.0317235775826019,-0.108745238990232,0.0156111851335674,0.142148219393021
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20663.Liking for fruit,18830,-0.0594598738709201,0.0349455748580583,-0.127953200592714,0.00903345285087425,0.0888657836174923
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20664.Liking for garlic,18830,-0.0158336698174226,0.0318921751773767,-0.078342333165081,0.0466749935302357,0.619565076533028
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20665.Liking for gherkins,18830,-0.0660508405209302,0.031333426084983,-0.127464355647497,-0.00463732539436364,0.0350442442923735
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20666.Liking for globe artichoke,18830,-0.000387533845775282,0.0316253720395306,-0.0623732630432553,0.0615981953517048,0.990223184623561
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20667.Liking for goat's cheese,18830,-0.00639186220166285,0.0312674059887896,-0.0676759779396904,0.0548922535363647,0.838023039463509
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20668.Liking for going to a cafe,18830,-0.0587249707278787,0.0316671885019773,-0.120792660191754,0.00334271873599686,0.0636915643225513
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20669.Liking for going to the gym,18830,0.090485880009652,0.0313923887550252,0.0289567980498026,0.152014961969501,0.00395086954295137
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20670.Liking for going to the pub,18830,0.064887187312497,0.0314219995166446,0.00330006825987363,0.12647430636512,0.0389343896955673
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20671.Liking for grapefruit,18830,0.0381672055617152,0.0313354639216859,-0.0232503037247891,0.0995847148482195,0.22323184940769
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20672.Liking for green olives,18830,0.0182942605744145,0.0314332483922816,-0.0433149062744573,0.0799034274232863,0.560571299723129
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20673.Liking for haddock,18830,-0.137364841344783,0.0322389725045635,-0.200553227453727,-0.0741764552358385,2.04657949851962e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20674.Liking for ham,18830,-0.00589117283697571,0.0315067179357465,-0.0676443399910388,0.0558619943170874,0.851677168417699
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20675.Liking for hard cheese,18830,-0.0490699810558183,0.0321672725614812,-0.112117835276321,0.0139778731646848,0.127160494401494
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20676.Liking for herring,18830,-0.0614545993980473,0.0313365982415087,-0.122874331951404,-3.4866844690222e-05,0.0498806164277095
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20677.Liking for honey,18830,-0.0137944535068744,0.031476989995415,-0.0754893538978879,0.0479004468841391,0.661217868690037
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20678.Liking for horseradish or wasabi,18830,0.00970030771993269,0.0313202832431812,-0.0516874474367025,0.0710880628765679,0.75678243280934
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20679.Liking for ice cream,18830,-0.0166162529328511,0.0316417021293782,-0.0786339891064324,0.0454014832407302,0.599493610897459
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20680.Liking for jam,18830,-0.00614953262982051,0.031439046380235,-0.067770063535081,0.05547099827544,0.84492400010563
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20681.Liking for kiwi fruit,18830,0.0131960894054083,0.0315783930212557,-0.0486975609162529,0.0750897397270696,0.67603706754302
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20682.Liking for lager,18830,0.0327731206927989,0.0317982536229909,-0.0295514564082632,0.095097697793861,0.30271453680714
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20683.Liking for lamb,18830,-0.0538730034156089,0.0318274113158842,-0.116254729594742,0.00850872276352409,0.0905366623250765
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20684.Liking for lemons,18830,-0.00506786881892353,0.031612889924152,-0.0670291330702614,0.0568933954324143,0.872638443250902
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20685.Liking for lentils or beans,18830,-0.00996669843889972,0.0318551749562401,-0.0724028413531304,0.052469444475331,0.754378848812521
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20686.Liking for liver,18830,-0.0706595704763567,0.0315818935805741,-0.132560081894282,-0.00875905905843134,0.0252755097728967
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20687.Liking for mackerel,18830,-0.0648988442890814,0.0315306267648311,-0.12669887274815,-0.00309881583001237,0.0395770519651492
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20688.Liking for marzipan,18830,-0.0312191715857777,0.0312008299563578,-0.092372798300239,0.0299344551286836,0.317038976447947
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20689.Liking for mayonnaise,18830,-0.0244095610230827,0.0315417562498013,-0.0862314032726933,0.0374122812265279,0.439010984755675
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20690.Liking for melon,18830,-0.0555482266585452,0.0324090686206431,-0.119070001155006,0.00797354783791528,0.0865503997853264
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20691.Liking for milk chocolate,18830,0.0393443966508732,0.0314810087521425,-0.0223583805033262,0.101047173805073,0.211394761763904
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20692.Liking for mushrooms,18830,-0.0585072969432309,0.0324193508592412,-0.122049224627344,0.00503463074088185,0.0711371729911217
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20694.Liking for orange juice,18830,0.0205588293632617,0.0313957154206111,-0.0409767728611361,0.0820944315876595,0.512585774487401
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20695.Liking for oranges,18830,-0.0307450725580886,0.0320332393041649,-0.0935302215942518,0.0320400764780745,0.3371749864694
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20696.Liking for pasta,18830,0.00749986409988744,0.0317308038721651,-0.0546925114895562,0.0696922396893311,0.813156608138961
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20697.Liking for pears,18830,-0.00251549753508661,0.032185794704025,-0.0655996551549757,0.0605686600848025,0.937705174755359
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20698.Liking for pizza,18830,0.0149573015941285,0.0315531757786631,-0.0468869229320511,0.0768015261203081,0.635480634641119
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20699.Liking for plain yogurt,18830,0.00844802737407102,0.0315334499809456,-0.0533575345885824,0.0702535893367244,0.788773955965569
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20700.Liking for plums,18830,-0.042296438038032,0.0321918588164787,-0.10539248131833,0.0207996052422662,0.188900539970159
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20701.Liking for pollock,18830,-0.0878460177735769,0.0313994739961932,-0.149388986806116,-0.0263030487410382,0.00515216852354452
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20702.Liking for pork chop,18830,-0.0544064009707044,0.0315299233995654,-0.116205050833853,0.00739224889244382,0.084445160701837
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20703.Liking for porridge,18830,-0.0479259928591491,0.032061004807052,-0.110765562280971,0.0149135765626727,0.134973630024039
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20704.Liking for potato crisps,18830,0.0267477252010748,0.0315955441389803,-0.0351795413113266,0.0886749917134763,0.397247635468402
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20705.Liking for potatoes,18830,-0.00159079218738118,0.0319129080272437,-0.0641400919207788,0.0609585075460164,0.960244106282516
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20706.Liking for prawns,18830,-0.0680696246251888,0.0320079437065674,-0.130805194290061,-0.00533405496031675,0.0334623357534683
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20707.Liking for raw carrots,18830,-0.00239611941850637,0.0317874082428304,-0.064699439574454,0.0599072007374412,0.939913559190495
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20708.Liking for red meat,18830,-0.0409619392316177,0.0315050100163885,-0.102711758863739,0.0207878804005038,0.193557878271201
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20709.Liking for red wine,18830,0.0625624923015443,0.0316307862190158,0.000566151312273361,0.124558833290815,0.0479547035684162
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,18830,0.0552554494962187,0.0322883348306001,-0.00802968677175744,0.118540585764195,0.0870398232172826
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20711.Liking for roast chicken,18830,-0.0867583384176336,0.0331099571457154,-0.151653854423236,-0.0218628224120313,0.0087920572371862
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20712.Liking for salad dressing,18830,-0.0172732655937945,0.0313795984316527,-0.0787772785198337,0.0442307473322448,0.582009310136159
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20713.Liking for salad leaves,18830,-0.0386832493616438,0.0320520806596867,-0.10150532745463,0.0241388287313421,0.227490725550259
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20714.Liking for salami,18830,0.0421701796243593,0.0313804867245884,-0.019335574355834,0.103675933604553,0.179018133119556
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20715.Liking for salmon,18830,-0.122328819932301,0.0328964912244922,-0.186805942732305,-0.0578516971322959,0.000200913482483183
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20716.Liking for salty foods,18830,0.0663578111486981,0.0312914611965337,0.00502654720349195,0.127689075093904,0.0339654648146527
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20717.Liking for salty pretzels,18830,0.0409253927022012,0.0314889183703484,-0.0207928873036817,0.102643672708084,0.193727955795227
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20718.Liking for sardines,18830,-0.0845912772915749,0.0313565307924148,-0.146050077644708,-0.0231324769384419,0.00698774808872224
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20719.Liking for sausages (meat),18830,-0.00839016970443188,0.0314749602367845,-0.0700810917685295,0.0533007523596658,0.789805881047322
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20720.Liking for savoury biscuits,18830,0.0178819237510747,0.0317111427596793,-0.0442719160578967,0.0800357635600461,0.572828691822977
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20721.Liking for shellfish (other than prawns),18830,-0.0537931750271294,0.0314703674490667,-0.1154750952273,0.0078887451730414,0.0874067374506774
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20722.Liking for skimmed milk,18830,-0.0783874838864624,0.0315293843298257,-0.140185077172921,-0.016589890600004,0.0129211535185158
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20723.Liking for smoked fish,18830,-0.0793772465644578,0.0315164100906458,-0.141149410342124,-0.017605082786792,0.011790451852998
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20724.Liking for soft cheese,18830,-0.0097146786557379,0.0315038960040907,-0.0714623148237557,0.0520329575122799,0.757808515080215
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20725.Liking for soy sauce,18830,-0.0601882162631393,0.0315781124031709,-0.122081316573354,0.00170488404707562,0.0566640623870867
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20726.Liking for soya milk,18830,-0.0184376957838001,0.0315763595466814,-0.0803273604952957,0.0434519689276955,0.559289067827877
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20727.Liking for spicy foods,18830,-0.0361572065486494,0.0315629688591739,-0.0980206255126302,0.0257062124153314,0.251992725108301
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20728.Liking for spinach,18830,-0.00595827092574996,0.0316170531564793,-0.0679276951124494,0.0560111532609495,0.850525017017068
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20729.Liking for spirits,18830,-2.6331810281079e-05,0.0314024984389921,-0.0615752287507055,0.0615225651301434,0.999330962051289
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20730.Liking for strawberries,18830,-0.0520726523182124,0.034420916324327,-0.119537648313893,0.0153923436774685,0.130342177803997
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20731.Liking for sweet coffee house drinks,18830,-0.028112617717593,0.0321191484777835,-0.0910661487340487,0.0348409132988627,0.381443430651131
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20732.Liking for sweet foods,18830,0.0429764266906191,0.0313231118282391,-0.0184168724927296,0.104369725873968,0.170068698991026
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20733.Liking for taking the stairs,18830,0.0450817624477148,0.0321654856312445,-0.0179625893895245,0.108126114284954,0.161064068914827
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20734.Liking for tea with sugar,18830,0.00993657749168108,0.0379664442307095,-0.0644776532005095,0.0843508081838716,0.793540192131858
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20735.Liking for tea without sugar,18830,-0.00615728795677694,0.0328907553883183,-0.0706231685178808,0.0583085926043269,0.851502541632757
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20736.Liking for tomato ketchup,18830,-0.0456792638223754,0.0313134972599484,-0.107053718451874,0.0156951908071234,0.144644476756384
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20737.Liking for tinned tuna,18830,-0.0672187723807165,0.0315594904022607,-0.129075373569148,-0.00536217119228546,0.0331922553554715
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20738.Liking for turnip (white),18830,-0.0517224156784878,0.0313734106053092,-0.113214300464894,0.00976946910791831,0.0992449330766189
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20739.Liking for vegetables,18830,-0.0591330168811196,0.0346263729752979,-0.127000707912704,0.00873467415046428,0.0877001637449986
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20740.Liking for vinegar,18830,-0.0844010456533478,0.0314830312560032,-0.146107786915114,-0.0226943043915815,0.0073501123682918
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20741.Liking for watching television,18830,-0.00275009201764645,0.031567157397645,-0.0646217205170307,0.0591215364817378,0.930578030951802
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20742.Liking for whisky,18830,0.0379706102470299,0.0324749554039492,-0.0256803023447105,0.10162152283877,0.242326811242159
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20743.Liking for white bread,18830,-0.0292842774773446,0.0312905985866513,-0.0906138507071812,0.0320452957524921,0.349346464599886
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20744.Liking for white rice,18830,0.0216539643752566,0.031518459620143,-0.0401222164802236,0.0834301452307368,0.492075552506285
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20745.Liking for white wine,18830,0.0994800301984189,0.0314522950630038,0.0378335318749315,0.161126528521906,0.00156461737357498
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,18830,0.00715125987387649,0.0317819876313785,-0.0551414358836255,0.0694439556313784,0.821974065871825
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20747.Liking for whole milk,18830,0.069135364997241,0.0313754124673285,0.0076395565612772,0.130631173433205,0.0275724026192141
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20748.Liking for wholemeal bread,18830,0.0113984743899658,0.0329031721551852,-0.0530917430341973,0.0758886918141288,0.729027375553214
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20749.Liking for working up a sweat,18830,0.158973593728336,0.0315905925448505,0.0970560323404295,0.220891155116243,4.89078889633392e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X21001.Body mass index (BMI),51826,-0.0495035869354014,0.00802234682223898,-0.0652273867069899,-0.033779787163813,6.84853403306907e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X21002.Weight,51866,0.0399250581480073,0.00452442401727517,0.031057187074148,0.0487929292218667,1.13454500810707e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X21021.Pulse wave Arterial Stiffness index,17267,-0.000523001980406303,0.00335692633910225,-0.00710257760504671,0.0060565736442341,0.87619417068267
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,17987,-0.0788795542621065,0.0338715650177924,-0.14526782169698,-0.0124912868272334,0.0198815505122292
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,18004,0.0708531048348846,0.0347138810577768,0.00281389796164215,0.138892311708127,0.0412594553961796
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,18006,-0.0136911814510882,0.0344148003642243,-0.0811441901649678,0.0537618272627914,0.690761477256327
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21040.Satisfaction with bowel habits,17928,-0.0987434504579288,0.0319971803682683,-0.161457923979735,-0.0360289769361229,0.00203175081815
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,17908,-0.0960709845314359,0.0340874821439213,-0.162882449533522,-0.0292595195293502,0.00483218105303348
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21042.Greatest number of times bowels opened per day,17918,0.0663359392531291,0.0344552263616892,-0.00119630441578175,0.13386818292204,0.0542102295411298
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21043.Least number of times bowels opened per week,17794,0.108963553504345,0.034245610098957,0.0418421577103888,0.1760849492983,0.00146601603073045
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21044.Average number of times bowels opened per day,17853,0.0084363108623945,0.0384434644658976,-0.0669128794907647,0.0837855012155537,0.826304212946621
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,18015,0.0390038293255193,0.0347000791429466,-0.029008325794656,0.107015984445695,0.261016519279
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,18005,0.0775523495783185,0.0348772743941168,0.00919289176584953,0.145911807390788,0.0261892022233754
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,10121,-0.077719653248993,0.0543595797791461,-0.184264429616119,0.0288251231181333,0.152824745538201
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,18010,0.0197877092327265,0.037810409210132,-0.0543206928191323,0.0938961112845853,0.600743935915709
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,18007,0.095285200146277,0.0522794072390005,-0.0071824380421641,0.197752838334718,0.0683784033449671
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,18008,0.0894389895339602,0.0407865985422363,0.0094972563911771,0.169380722676743,0.0283307726870504
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,18006,-0.0691992930301419,0.101328490622155,-0.267803134649566,0.129404548589282,0.494665938072201
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,18014,0.00786929307840857,0.039818878759879,-0.0701757092909542,0.0859142954477713,0.843338992281696
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,18010,0.133445020792041,0.0396604252373141,0.055710587326905,0.211179454257176,0.00076789858031442
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,17598,0.00593124399321501,0.036153440219242,-0.0649294988364993,0.0767919868229294,0.86968774308267
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,18004,0.0204554443821412,0.0355222091442065,-0.0491680855405034,0.0900789743047859,0.564724153540828
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,18011,0.137452357218466,0.0514179600091843,0.0366731556004643,0.238231558836467,0.00751910777017984
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,18014,0.132964356258651,0.0348252578716737,0.0647068508301709,0.201221861687132,0.000134964935235981
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,18011,0.0627037344938523,0.0347561077906311,-0.00541823677578465,0.130825705763489,0.071231261358725
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X21100.Water hardness (USGS classification),51549,0.0121998360446512,0.0200807610894167,-0.0271584556906056,0.0515581277799079,0.543496258646861
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2139.Age first had sexual intercourse,44968,0.0102444634423579,0.00207312592961168,0.00618113662031905,0.0143077902643968,7.77805292650337e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2149.Lifetime number of sexual partners,41733,0.0278261728062189,0.0227141505001164,-0.0166935621740093,0.0723459077864471,0.220559936225901
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22032.IPAQ activity group,41682,0.114007714615457,0.022318308553053,0.0702638298514728,0.15775159937944,3.26570902711321e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22033.Summed days activity,42784,0.00977695621810516,0.00201531637342188,0.00582693612619828,0.013726976310012,1.23069812134869e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22034.Summed minutes activity,41682,0.0118165194871833,0.00203366325961164,0.00783053949834446,0.0158024994760221,6.27537313222018e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22037.MET minutes per week for walking,39901,0.00734673604709106,0.00207806448448957,0.00327372965749149,0.0114197424366906,0.000407658872455169
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22038.MET minutes per week for moderate activity,41682,0.00772356515062945,0.00203609223678241,0.00373282436653592,0.011714305934723,0.000148851619527951
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22039.MET minutes per week for vigorous activity,41682,0.139345963960691,0.022308192587677,0.095621906488844,0.183070021432538,4.24060219782271e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22040.Summed MET minutes per week for all activity,39901,0.0127339326930561,0.00208500560190025,0.00864732171333156,0.0168205436727805,1.02210201109489e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X2217.Age started wearing glasses or contact lenses,44250,0.00475958797987389,0.00201632425339447,0.00080759244322074,0.00871158351652705,0.0182533003489475
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X22501.Year ended full time education,12651,0.00556355313924267,0.00921539082135006,-0.0124986128706035,0.0236257191490888,0.546037953266388
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X22506.Tobacco smoking,12569,0.247683184817824,0.0800874811187694,0.0907117218250361,0.404654647810612,0.00198807816761642
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,48651,-0.0382803995838881,0.0524820474826367,-0.141145212649856,0.0645844134820798,0.465760598529873
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23098.Weight,50987,0.0399592900073011,0.00456346494528925,0.0310148987145342,0.048903681300068,2.07726044266972e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23099.Body fat percentage,50957,-0.00773984925909844,0.00437946502288742,-0.0163236007039578,0.000843902185760902,0.0771831936695251
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23100.Whole body fat mass,50905,0.00408316724394037,0.00423077692204329,-0.00420915552326447,0.0123754900111452,0.334494052770841
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23101.Whole body fat-free mass,50981,0.0266528554102181,0.00381685918252451,0.0191718114124701,0.0341338994079662,2.9261700041615e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23102.Whole body water mass,50987,0.0260175522002919,0.00382205757636872,0.0185263193506092,0.0335087850499746,1.00607088107224e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23104.Body mass index (BMI),50987,-0.0503854349469811,0.00806585584154764,-0.0661945123964145,-0.0345763574975477,4.22364041162078e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23105.Basal metabolic rate,50985,0.0302378533406399,0.00408379127664689,0.022233622438412,0.0382420842428678,1.33813434250063e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23106.Impedance of whole body,50981,0.00384856098079774,0.0031246643976287,-0.00227578123855451,0.00997290320014999,0.218077395763947
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23107.Impedance of leg (right),50984,-0.0112199579702621,0.0025505626006075,-0.0162190606674528,-0.00622085527307139,1.0896449736762e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23108.Impedance of leg (left),50983,-0.0110838563971144,0.00253254128944029,-0.0160476373244173,-0.00612007546981142,1.2079820228126e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23109.Impedance of arm (right),50974,0.0149502315863431,0.00311280615319457,0.00884913152608176,0.0210513316466045,1.56894271371353e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23110.Impedance of arm (left),50982,0.0164765452917326,0.0031157814058441,0.0103696137362781,0.022583476847187,1.24105762792007e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23111.Leg fat percentage (right),50983,-0.0418278719077584,0.0052938763331541,-0.0522038695207404,-0.0314518742947764,2.81773373225609e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23112.Leg fat mass (right),50982,-0.0165547645487918,0.00563485578697947,-0.0275990818912715,-0.005510447206312,0.0033056850414859
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23113.Leg fat-free mass (right),50981,0.0395511300779512,0.00399234099822839,0.0317261417214236,0.0473761184344789,4.08282480149248e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23114.Leg predicted mass (right),50980,0.0400863560877702,0.00401215057786378,0.0322225409551572,0.0479501712203832,1.74986627858108e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23115.Leg fat percentage (left),50977,-0.0444778322342005,0.00551489797017326,-0.05528703225574,-0.0336686322126609,7.47977703234406e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23116.Leg fat mass (left),50977,-0.014295656170286,0.00587535032603166,-0.025811342809308,-0.00277996953126393,0.0149711790349108
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23117.Leg fat-free mass (left),50974,0.0404022710747095,0.0041685938801126,0.0322318270696888,0.0485727150797302,3.40591881670596e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23118.Leg predicted mass (left),50973,0.0405464309988263,0.00418969005958436,0.032334638482041,0.0487582235156117,3.92009100868466e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23119.Arm fat percentage (right),50973,-0.00938934932815124,0.00486409074076469,-0.01892296718005,0.000144268523747547,0.0535702556206313
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23120.Arm fat mass (right),50969,0.0126812169506154,0.0048177979323869,0.0032383330031371,0.0221241008980937,0.00848693670040766
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23121.Arm fat-free mass (right),50969,0.0230442946551488,0.00384368474014532,0.015510672564464,0.0305779167458336,2.04390044496384e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23122.Arm predicted mass (right),50968,0.0227252734983487,0.00384803860241272,0.0151831178376197,0.0302674291590776,3.5342206172842e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23123.Arm fat percentage (left),50963,-0.00332541101629265,0.00498537345502026,-0.0130967429881324,0.00644592095554707,0.504753767506061
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23124.Arm fat mass (left),50962,0.0150154872524767,0.00480773362464917,0.00559232934816437,0.0244386451567891,0.00178999678035735
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23125.Arm fat-free mass (left),50958,0.0228058162760208,0.0039176265059448,0.015127268324369,0.0304843642276726,5.87284970550122e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23126.Arm predicted mass (left),50955,0.0221387666511323,0.00393114762730832,0.014433717301608,0.0298438160006567,1.79453099736501e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23127.Trunk fat percentage,50951,0.00313560588248236,0.00314038164438045,-0.00301954214050331,0.00929075390546803,0.318051768653365
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23128.Trunk fat mass,50947,0.00942483871802368,0.00345610243689975,0.00265087794170018,0.0161987994943472,0.00639322583466219
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23129.Trunk fat-free mass,50940,0.0170626645347763,0.00346100057587919,0.0102791034060531,0.0238462256634995,8.24960504725488e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23130.Trunk predicted mass,50935,0.0167947443114506,0.00346300418026319,0.0100072561181347,0.0235822325047664,1.2397426086211e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23400.Total Cholesterol,29786,0.0213883912871507,0.00249725155263735,0.0164937782439815,0.0262830043303199,1.13425020953324e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,29786,0.0237593904525156,0.00241907795963995,0.0190179976516213,0.02850078325341,9.83476921018001e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",29786,0.0267958703560089,0.00242311271508022,0.0220465694344517,0.0315451712775661,2.26596173642601e-28
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23403.VLDL Cholesterol,29786,0.0296027304417515,0.00242767568308189,0.024844486102911,0.034360974780592,4.04303434886281e-34
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23404.Clinical LDL Cholesterol,29786,0.0188173032406372,0.00242301238174423,0.0140681989724185,0.0235664075088559,8.35450010285117e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23405.LDL Cholesterol,29786,0.020310516814136,0.00241563059023588,0.0155758808572737,0.0250451527709984,4.35581382010193e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23406.HDL Cholesterol,29786,-0.00206247944410444,0.00281221043270008,-0.00757441189219661,0.00344945300398772,0.463319338888078
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23407.Total Triglycerides,29786,0.0244851395878785,0.00257418871132242,0.0194397297136866,0.0295305494620705,2.0102170597704e-21
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23408.Triglycerides in VLDL,29786,0.0238734702318728,0.00259355071482772,0.0187901108308104,0.0289568296329351,3.63588624860758e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23409.Triglycerides in LDL,29786,0.0218988597391674,0.00249549255521218,0.0170076943309515,0.0267900251473832,1.79261515222481e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23410.Triglycerides in HDL,29786,0.0232002025602775,0.00248059719308302,0.0183382320618348,0.0280621730587202,9.125691475662e-21
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,29786,0.021261226568649,0.00253498008086909,0.0162926656101455,0.0262297875271524,5.19831109337789e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23412.Phospholipids in VLDL,29786,0.0289674868263822,0.00248463140222224,0.0240976092780266,0.0338373643747377,2.42484635851005e-31
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23413.Phospholipids in LDL,29786,0.0190704728609729,0.00241070378102711,0.0143454934501598,0.0237954522717861,2.64661609172793e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23414.Phospholipids in HDL,29786,0.00198457623727433,0.00271269759768075,-0.00333231105417993,0.0073014635287286,0.464426006870021
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23415.Total Esterified Cholesterol,29786,0.0199605922138441,0.00251016906810007,0.015040660840368,0.0248805235873203,1.90148083274878e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,29786,0.0294380418968508,0.00241372641481511,0.0247071381238132,0.0341689456698884,3.93390931144297e-34
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23417.Cholesteryl Esters in LDL,29786,0.0214533604287188,0.00241046196759247,0.0167288549722376,0.0261778658852001,5.88855378339635e-19
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23418.Cholesteryl Esters in HDL,29786,-0.0044126446237816,0.00280281552044198,-0.00990616304384789,0.00108087379628468,0.115414543264782
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23419.Total Free Cholesterol,29786,0.0245792221127516,0.00246676185977776,0.0197443688675872,0.029414075357916,2.37927607874434e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23420.Free Cholesterol in VLDL,29786,0.029126168322707,0.00246091513706942,0.024302774654051,0.0339495619913631,3.02176678068643e-32
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23421.Free Cholesterol in LDL,29786,0.0166108183440747,0.00244032048210194,0.0118277901991549,0.0213938464889945,1.01672149794029e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23422.Free Cholesterol in HDL,29786,0.00604678607947493,0.00281108489666424,0.000537059682013025,0.0115565124769368,0.0314802214558812
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,29786,0.0253812035986579,0.00244607452103628,0.0205868975374268,0.0301755096598891,3.50900477422086e-25
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23424.Total Lipids in VLDL,29786,0.0283123584952062,0.00251724459359307,0.0233785590917637,0.0332461578986486,2.73419491589589e-29
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23425.Total Lipids in LDL,29786,0.0207426307373768,0.00241217384914872,0.0160147699930453,0.0254704914817083,8.41835764946327e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23426.Total Lipids in HDL,29786,0.00260968833597102,0.00275076271985564,-0.00278180659494603,0.00800118326688807,0.342773564238149
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,29786,0.00624165237039253,0.0025820415391656,0.00118085095362794,0.0113024537871571,0.0156407050758517
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23428.Concentration of VLDL Particles,29786,0.0289430107199028,0.00244889922483522,0.0241431682392257,0.0337428532005798,3.68416133448854e-32
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23429.Concentration of LDL Particles,29786,0.0243018486032546,0.00240480471786685,0.0195884313562356,0.0290152658502736,5.70714575110581e-24
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23430.Concentration of HDL Particles,29786,0.00213129057459044,0.00259129172789248,-0.00294764121207881,0.0072102223612597,0.410809264300218
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23431.Average Diameter for VLDL Particles,29786,0.0191507590161246,0.00269435082105401,0.0138698314068588,0.0244316866253905,1.20607756562701e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23432.Average Diameter for LDL Particles,29786,-0.00902205490500513,0.00252263821335257,-0.0139664258031762,-0.00407768400683408,0.000348861988857768
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23433.Average Diameter for HDL Particles,29786,0.00518041593098288,0.00287870483342587,-0.000461845542531815,0.0108226774044976,0.0719395021330362
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23434.Phosphoglycerides,29763,0.0178300364735825,0.00255219484068369,0.0128277345858424,0.0228323383613225,2.88456190369821e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,29763,0.0207452306426357,0.00273322704105056,0.0153881056421766,0.0261023556430948,3.29222327473339e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23436.Total Cholines,29763,0.0182337809242539,0.00257464808332891,0.0131874706809292,0.0232800911675785,1.45192002711165e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23437.Phosphatidylcholines,29763,0.0191011318960409,0.00258449697032046,0.0140355178342128,0.024166745957869,1.49945843403115e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23438.Sphingomyelins,29762,0.0140150436399086,0.00259301765109121,0.00893272904376979,0.0190973582360474,6.5336638705426e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23439.Apolipoprotein B,29786,0.0251450645740297,0.00240778943062305,0.0204257972900085,0.0298643318580508,1.7419280163146e-25
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23440.Apolipoprotein A1,29786,0.00316577208696022,0.0026779097929009,-0.00208293110712553,0.00841447528104598,0.237143626307839
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,29786,0.020877807277873,0.00245866559722907,0.016058822707304,0.0256967918484419,2.1329521999041e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23442.Total Fatty Acids,29763,0.0236508619492745,0.00245415102411579,0.0188407259420075,0.0284609979565414,6.00235855507786e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23443.Degree of Unsaturation,29763,-0.00836195122068231,0.00265490416476205,-0.0135655633836159,-0.00315833905774869,0.00163642197389649
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23444.Omega-3 Fatty Acids,29763,0.0178668556201293,0.00250149029345443,0.0129639346449586,0.0227697765953,9.37628707834058e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23445.Omega-6 Fatty Acids,29763,0.0200400638605038,0.00245548966679984,0.0152273041135761,0.0248528236074315,3.44302992894343e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,29763,0.0213650854114013,0.00246754064569971,0.0165287057458299,0.0262014650769727,5.0192451962891e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23447.Monounsaturated Fatty Acids,29763,0.0220507047250897,0.00251644005769648,0.0171184822120046,0.0269829272381748,2.00625033531253e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23448.Saturated Fatty Acids,29763,0.0234524351288387,0.00246711718673988,0.0186168854428285,0.0282879848148489,2.12483840123936e-21
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23449.Linoleic Acid,29763,0.0227433707118458,0.00244521154309259,0.0179507560873843,0.0275359853363073,1.48097530492322e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23450.Docosahexaenoic Acid,29763,0.00764492551138614,0.00257326574511229,0.00260132465096605,0.0126885263718062,0.00297161808274078
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,29763,0.00783354421018916,0.00252260205562443,0.00288924418116527,0.0127778442392131,0.00190237128461878
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,29763,-0.016020683533719,0.0026301487140282,-0.0211757750132142,-0.0108655920542237,1.1346130396223e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,29763,-0.0134078973155714,0.00268002960069104,-0.0186607553329259,-0.00815503929821699,5.67981828763298e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,29763,0.0119655426707548,0.00272625813166152,0.00662207673269827,0.0173090086088114,1.14265696199982e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,29763,0.00955101583617908,0.00246609855769185,0.00471746266310305,0.0143845690092551,0.000107766754355913
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,29763,0.00206083874700902,0.00262580219636934,-0.00308573355787488,0.00720741105189292,0.432552707083164
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,29763,-0.00689550844820297,0.0025860510199752,-0.0119641684473544,-0.00182684844905158,0.00767043925524852
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,29763,-0.0131740453227781,0.00272808636768042,-0.0185210946034317,-0.00782699604212443,1.37872260280714e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,29761,-0.0115208261144355,0.00249667232416837,-0.0164143038698055,-0.00662734835906553,3.95737709908907e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23460.Alanine,29776,0.00661393707982498,0.00244796305533352,0.00181592949137128,0.0114119446682787,0.00690017209441981
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23461.Glutamine,29697,0.014804750881372,0.00243576481338961,0.0100306518471284,0.0195788499156156,1.2311784580552e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23462.Glycine,29751,0.0227693000328613,0.00257350776903065,0.0177252248055612,0.0278133752601614,9.42855277481891e-19
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23463.Histidine,29749,-0.00672191618974724,0.0024212789524784,-0.0114676229366049,-0.00197620944288959,0.005503543859769
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),29764,0.00654332177499547,0.00256640053798511,0.00151317672054465,0.0115734668294463,0.0107893035677181
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23465.Isoleucine,29780,0.00297791086819083,0.00250392310231066,-0.00192977841233806,0.00788560014871973,0.23433188842438
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23466.Leucine,29781,0.00766752230500002,0.00256009397893862,0.00264973810628032,0.0126853065037197,0.00274656174233408
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23467.Valine,29764,0.00636633888303791,0.00257041303241277,0.00132832933950887,0.0114043484265669,0.0132630006857026
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23468.Phenylalanine,29775,-0.0025431033678117,0.00244792822594336,-0.00734104269066068,0.00225483595503728,0.29886904749012
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23469.Tyrosine,29753,0.00499724169925697,0.00248754601908307,0.000121651501854161,0.00987283189665978,0.0445563128204954
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23470.Glucose,29732,-0.0208149220248124,0.00245943606136236,-0.0256354167050826,-0.0159944273445421,2.71707398518997e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23471.Lactate,29733,0.0172675777671636,0.00243662768917233,0.0124917874963859,0.0220433680379414,1.40436801634565e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23472.Pyruvate,29696,0.00313561032111834,0.0024387473129994,-0.00164433441236049,0.00791555505459717,0.198541649304234
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23473.Citrate,29782,0.00502407878921907,0.0024684671797518,0.000185883116905547,0.00986227446153259,0.0418292283369117
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23474.3-Hydroxybutyrate,29297,-0.0186532448917219,0.00247697082640249,-0.0235081077114708,-0.013798382071973,5.19346827467193e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23475.Acetate,29761,-0.00505615177128092,0.00243240387412757,-0.00982366336457096,-0.000288640177990878,0.0376567406582489
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23476.Acetoacetate,29784,-0.0210093205279468,0.00243253644837779,-0.0257770919667673,-0.0162415490891264,6.06477515194038e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23477.Acetone,29784,-0.00959349271844988,0.0024350171934924,-0.014366126417695,-0.00482085901920479,8.17338518273168e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23478.Creatinine,29037,0.0127374296380487,0.00289390629258908,0.00706537330457408,0.0184094859715233,1.07905361040929e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23479.Albumin,29783,0.00469178269191133,0.00246609643064722,-0.000141766312157222,0.00952533169597988,0.0571136457130934
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23480.Glycoprotein Acetyls,29786,-0.00389469725408344,0.00258831224519564,-0.00896778925466689,0.00117839474650002,0.13240548937175
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,29786,0.022166371259264,0.00260297798616816,0.0170645344063744,0.0272682081121535,1.73150055931722e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,29786,0.0213437508288943,0.0025975886079109,0.0162524771573889,0.0264350245003996,2.1747259553648e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,29786,0.0207837161475698,0.0026131431194661,0.0156619556334162,0.0259054766617233,1.87651960215581e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,29786,0.0244097587555879,0.00258789454073049,0.0193374854557561,0.0294820320554196,4.29407073709769e-21
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,29786,0.0260338340908634,0.00257749641965408,0.0209819411083414,0.0310857270733854,6.01110999988886e-24
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,29786,0.0219441915892067,0.00258973982167078,0.0168683015387319,0.0270200816396814,2.48917459186856e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,29786,0.0205965734990187,0.00258575189563844,0.0155284997835674,0.0256646472144701,1.7051093243292e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,29786,0.0250445082467618,0.00261423442096766,0.0199206087816652,0.0301684077118584,1.0424695458813e-21
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,29786,0.025060571975581,0.00261031885819796,0.019944347013513,0.030176796937649,8.54938757643565e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,29786,0.02627878419848,0.00259429442719402,0.0211939671211798,0.0313636012757803,4.47401880804585e-24
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,29786,0.0283708839269708,0.00253864348142333,0.0233951427033811,0.0333466251505605,6.12996403353035e-29
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,29786,0.0284354267001521,0.00250355524570957,0.0235284584185613,0.0333423949817429,7.79464842656351e-30
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,29786,0.0271600577780331,0.00257227704176664,0.0221183947761705,0.0322017207798957,5.14459941379293e-26
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,29786,0.0220914015107195,0.00263622572715958,0.0169243990854867,0.0272584039359523,5.52566925249061e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23495.Concentration of Large VLDL Particles,29786,0.0258746370936972,0.00258121472226085,0.0208154562380659,0.0309338179493285,1.30061023984174e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23496.Total Lipids in Large VLDL,29786,0.0254136656203134,0.0025762482425491,0.0203642190649171,0.0304631121757096,6.4266930724435e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23497.Phospholipids in Large VLDL,29786,0.0258424260609212,0.00259015411647141,0.0207657239926373,0.0309191281292052,2.08801485023516e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23498.Cholesterol in Large VLDL,29786,0.027442747063363,0.00252674752213262,0.0224903219199831,0.032395172206743,1.99268346987162e-27
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,29786,0.02811225981477,0.00248065513417938,0.0232501757517784,0.0329743438777616,1.0410668718109e-29
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,29786,0.0259954479553141,0.00257780071314846,0.0209429585575431,0.0310479373530851,7.07759134231602e-24
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23501.Triglycerides in Large VLDL,29786,0.0231358687121157,0.00258782730198786,0.0180637272002195,0.0282080102240119,4.10131502503519e-19
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,29786,0.0276056190572319,0.00242612995778897,0.0228504043399655,0.0323608337744983,6.17377811938267e-30
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23503.Total Lipids in Medium VLDL,29786,0.0275852583677348,0.00244685744703553,0.0227894177715451,0.0323810989639244,2.02921150079846e-29
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23504.Phospholipids in Medium VLDL,29786,0.0279911202652972,0.0024201526223555,0.0232476211254804,0.032734619405114,7.14605025463208e-31
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23505.Cholesterol in Medium VLDL,29786,0.024392756195027,0.00241428996474735,0.0196607478641222,0.0291247645259318,5.82725922027503e-24
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,29786,0.0210562936068466,0.00243949089312055,0.0162748914563303,0.0258376957573629,6.35547143799082e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,29786,0.0270027159926737,0.00241099910648902,0.0222771577439552,0.0317282742413922,4.67163279001728e-29
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23508.Triglycerides in Medium VLDL,29786,0.0243387272344792,0.0025406842991977,0.0193589860080517,0.0293184684609067,1.0471009867241e-21
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23509.Concentration of Small VLDL Particles,29786,0.0264138082304711,0.00247965710471916,0.0215536803052216,0.0312739361557207,1.90039305648552e-26
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23510.Total Lipids in Small VLDL,29786,0.0265054357769084,0.00247030448662027,0.0216636389831326,0.0313472325706841,8.2731656099177e-27
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23511.Phospholipids in Small VLDL,29786,0.0259508572618375,0.00242753050829758,0.0211928974655742,0.0307088170581007,1.26405032273963e-26
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23512.Cholesterol in Small VLDL,29786,0.0264354654027069,0.00242041227834016,0.0216914573371602,0.0311794734682536,1.02264688070969e-27
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,29786,0.026815129558659,0.00243100770110099,0.0220503544645011,0.031579904652817,3.09061703459836e-28
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,29786,0.0250900761666433,0.00240957926535397,0.0203673008065495,0.0298128515267371,2.40023583482987e-25
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23515.Triglycerides in Small VLDL,29786,0.0212374588949681,0.00254973930786167,0.0162399698515592,0.026234947938377,8.47922632036095e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,29786,0.0284953989638877,0.00244336517638034,0.0237064032181823,0.0332843947095932,2.32239932146285e-31
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,29786,0.0281956965143292,0.00245162373607879,0.0233905139916148,0.0330008790370436,1.5160549077479e-30
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,29786,0.0268056279341385,0.00244837125935945,0.022006820265794,0.031604435602483,7.64735877719766e-28
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,29786,0.0268973275176156,0.00248236513709033,0.0220318918489185,0.0317627631863126,2.63189437813318e-27
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,29786,0.0264386742080327,0.00250151788953974,0.0215356991445349,0.0313416492715306,4.61207052703245e-26
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,29786,0.0267918119522531,0.00245173404311049,0.0219864132277566,0.0315972106767497,9.59456894646452e-28
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,29786,0.0214934169983376,0.00250926330054659,0.0165752609292663,0.0264115730674089,1.12587584474236e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23523.Concentration of IDL Particles,29786,0.0224304023797493,0.00243715129040648,0.0176535858505526,0.027207218908946,3.68357941936132e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23524.Total Lipids in IDL,29786,0.0215797438851424,0.0024992055387707,0.0166813010291519,0.026478186741133,6.17984994818996e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23525.Phospholipids in IDL,29786,0.0233158333732488,0.0025013273119962,0.0184132318417362,0.0282184349047613,1.22509902380187e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23526.Cholesterol in IDL,29786,0.0191104080073174,0.00250998482446926,0.0141908377513576,0.0240299782632771,2.74120913988189e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23527.Cholesteryl Esters in IDL,29786,0.0191123156846592,0.00250908354907154,0.014194511928479,0.0240301194408394,2.66816148560544e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23528.Free Cholesterol in IDL,29786,0.0185476815132099,0.00250851092793304,0.0136310000944611,0.0234643629319587,1.46334895406834e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23529.Triglycerides in IDL,29786,0.0221597481607535,0.00248603352457465,0.0172871224525872,0.0270323738689198,5.21100833317508e-19
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23530.Concentration of Large LDL Particles,29786,0.0224246344626073,0.00240961161001908,0.0177017957069699,0.0271474732182447,1.41118518263992e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23531.Total Lipids in Large LDL,29786,0.0201853912130814,0.0024303055094111,0.0154219924146357,0.0249487900115272,1.03389862713763e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23532.Phospholipids in Large LDL,29786,0.0189751522454152,0.00242747804780693,0.0142172952717136,0.0237330092191168,5.59555637592757e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23533.Cholesterol in Large LDL,29786,0.0196379811490752,0.00243645323249936,0.0148625328133764,0.0244134294847739,7.90836498254402e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,29786,0.0201625034311329,0.00242798824441851,0.0154036464720726,0.0249213603901932,1.04700971395506e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23535.Free Cholesterol in Large LDL,29786,0.0177111369971154,0.0024648773743211,0.012879977343446,0.0225422966507848,6.85832584428914e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23536.Triglycerides in Large LDL,29786,0.0207339061159344,0.00248539839589397,0.0158625252599822,0.0256052869718866,7.59753600493222e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23537.Concentration of Medium LDL Particles,29786,0.0250047191080818,0.0024075606582909,0.0202859002178317,0.029723537998332,3.17395810713461e-25
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23538.Total Lipids in Medium LDL,29786,0.0210491034470404,0.00240672899462297,0.0163319146175794,0.0257662922765014,2.32584464418812e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23539.Phospholipids in Medium LDL,29786,0.0190893896909981,0.00240485509816013,0.0143758736986042,0.023802905683392,2.12895508451203e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23540.Cholesterol in Medium LDL,29786,0.020893680070434,0.00240513729333417,0.016179610975499,0.025607749165369,3.90464218360382e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,29786,0.022553827759232,0.00241139598941886,0.0178274916199711,0.027280163898493,9.09572544427986e-21
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,29786,0.015340234303658,0.00241111735018954,0.0106144442972865,0.0200660243100295,2.0165092785615e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23543.Triglycerides in Medium LDL,29786,0.0221384544342557,0.00250886244992129,0.01722108403241,0.0270558248361014,1.16246798209185e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23544.Concentration of Small LDL Particles,29786,0.0275955906368078,0.00240576697209135,0.0228802873715088,0.0323108939021069,2.14753704987312e-30
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23545.Total Lipids in Small LDL,29786,0.0217867434000272,0.00240443316923354,0.0170740543883295,0.026499432411725,1.36869866132104e-19
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23546.Phospholipids in Small LDL,29786,0.0175546496676701,0.00240408199586442,0.0128426489557758,0.0222666503795643,2.90582082234346e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23547.Cholesterol in Small LDL,29786,0.0216479616741068,0.00240291529428968,0.0169382476972991,0.0263576756509146,2.19964441955707e-19
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,29786,0.0244429002963071,0.00240718917693998,0.0197248095095047,0.0291609910831095,3.47832867113355e-24
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23549.Free Cholesterol in Small LDL,29786,0.0126811208070445,0.00241212471208921,0.0079533563713496,0.0174088852427393,1.47240452183121e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23550.Triglycerides in Small LDL,29786,0.0250982976148031,0.00253615462571676,0.0201274345483983,0.030069160681208,4.69334592453219e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,29786,0.0150747985069307,0.00283209030666469,0.00952390150586787,0.0206256955079935,1.02891392381176e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23552.Total Lipids in Very Large HDL,29786,0.00823585257789357,0.00284513976556311,0.00265937863738988,0.0138123265183973,0.00379785457229572
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23553.Phospholipids in Very Large HDL,29786,0.00649148779081639,0.00283763390613776,0.000929725334786384,0.0120532502468464,0.0221654127676464
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23554.Cholesterol in Very Large HDL,29786,0.0061554614461229,0.00285059660721287,0.00056829209598568,0.0117426307962601,0.0308302861160924
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,29786,0.00534293480246286,0.00288205672719194,-0.000305896382833336,0.010991765987759,0.0637688216299643
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,29786,0.00812962789803504,0.00270610053705996,0.00282567084539752,0.0134335849506726,0.00266514355492298
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23557.Triglycerides in Very Large HDL,29786,0.0298904166554323,0.00244815817416213,0.0250920266340746,0.0346888066767901,3.34567367318772e-34
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23558.Concentration of Large HDL Particles,29786,0.00478859671834195,0.00292949748672963,-0.000953218355648137,0.010530411792332,0.102140626833983
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23559.Total Lipids in Large HDL,29786,0.00169356828988265,0.00290854437752803,-0.0040071786900723,0.00739431526983759,0.560386887318503
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23560.Phospholipids in Large HDL,29786,-0.000368729397819502,0.00287517998248288,-0.00600408216348594,0.00526662336784693,0.897955421205218
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23561.Cholesterol in Large HDL,29786,-3.77705935780383e-05,0.00292864819815847,-0.00577792106196865,0.00570237987481257,0.989710104141008
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,29786,-0.00120035804621367,0.00292874029031262,-0.0069406890152264,0.00453997292279907,0.681915468040682
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23563.Free Cholesterol in Large HDL,29786,0.00358798307801405,0.00291192431779685,-0.00211938858486778,0.00929535474089588,0.217895665586855
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23564.Triglycerides in Large HDL,29786,0.0260981917842394,0.00250412441462979,0.021190107931565,0.0310062756369138,2.17416780087635e-25
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23565.Concentration of Medium HDL Particles,29786,-0.000157550612887365,0.00265360203942325,-0.00535861061015694,0.00504350938438221,0.952655927034836
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23566.Total Lipids in Medium HDL,29786,-0.000820293232093086,0.00262061745295986,-0.00595670343989441,0.00431611697570823,0.75427126725628
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23567.Phospholipids in Medium HDL,29786,-2.33751788835345e-05,0.0025908505257441,-0.00510144220934197,0.0050546918515749,0.992801481788192
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23568.Cholesterol in Medium HDL,29786,-0.00578327204799322,0.00267237574478957,-0.0110211285077808,-0.000545415588205654,0.0304650685238398
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,29786,-0.00733069487036591,0.00266340030605622,-0.0125509594702361,-0.00211043027049572,0.00591992931626099
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,29786,0.000669384572122793,0.00269586618751584,-0.00461451315540825,0.00595328229965384,0.803903725212086
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23571.Triglycerides in Medium HDL,29786,0.0208653984534981,0.00248219125509179,0.0160003035935182,0.025730493313478,4.42738058455582e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23572.Concentration of Small HDL Particles,29786,0.00220559341776639,0.00241631770339006,-0.00253038928087812,0.0069415761164109,0.361359784515164
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23573.Total Lipids in Small HDL,29786,0.00392225104054701,0.00243288799110407,-0.000846209422016961,0.00869071150311098,0.106933583198746
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23574.Phospholipids in Small HDL,29786,0.00344864596314727,0.00244430557397551,-0.00134219296184473,0.00823948488813928,0.158287539604879
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23575.Cholesterol in Small HDL,29786,-0.0001901031752445,0.00241705426180439,-0.0049275295283811,0.00454732317789209,0.937310933713391
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,29786,-0.0033323843101357,0.00241013291863032,-0.00805624483065113,0.00139147621037973,0.166780794810399
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23577.Free Cholesterol in Small HDL,29786,0.00952461172501107,0.00245682299129637,0.00470923866207019,0.014339984787952,0.000106066295653707
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23578.Triglycerides in Small HDL,29786,0.0197865922550633,0.00260099178176205,0.0146886483628096,0.0248845361473169,2.88073161126111e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28521,-0.00655910754684174,0.00247466173932964,-0.0114094445559278,-0.00170877053775564,0.0080415518563023
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28521,-0.000126966365058127,0.00250708330544213,-0.0050408496437247,0.00478691691360844,0.959610306379295
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28521,0.00471114855831433,0.00248193400496636,-0.000153442091419742,0.0095757392080484,0.0576829390299067
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28521,-0.00889501356037148,0.00253478830211666,-0.0138631986325201,-0.00392682848822282,0.000450193357973377
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,28521,0.00122713744891257,0.00247218099230309,-0.00361833729600149,0.00607261219382664,0.619631230913043
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,29470,0.0199207849686676,0.00241968398752407,0.0151782043531205,0.0246633655842148,1.90357945846203e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,29470,0.000774171509034631,0.00264105953424921,-0.00440230517809381,0.00595064819616307,0.769425509251703
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,29470,-0.00151941941127997,0.0026367729535444,-0.006687494400227,0.00364865557766706,0.564455999609303
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,29470,0.00998090446555632,0.00256224244868441,0.00495890926613487,0.0150028996649778,9.82619318952399e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,29470,-0.00800230954129994,0.00257532048834812,-0.0130499376984623,-0.00295468138413763,0.0018898020763172
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,29781,0.0189653436438631,0.0025607272271184,0.013946318278711,0.0239843690090151,1.33379896762703e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,29781,0.00784892124303679,0.00248577350454101,0.00297680517413641,0.0127210373119372,0.00159266972037835
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,29781,0.00714296108836663,0.00257660542682002,0.00209281445179939,0.0121931077249339,0.00557070665806027
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,29781,0.00716820336371129,0.00243398548566373,0.00239759181181038,0.0119388149156122,0.00323154629390663
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,29781,-0.0135344824536438,0.00240988490362264,-0.0182578568647442,-0.00881110804254341,1.96901336142248e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,29786,0.014029289479139,0.00254046125310596,0.00904998542305127,0.0190085935352267,3.37306583359182e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,29786,0.003099902,0.002651109,-0.002096272,0.008296077,0.2422982
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,29786,0.000947617105742264,0.00267011600650726,-0.00428581026701197,0.0061810444784965,0.722669004646074
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,29786,0.00864668589126432,0.00258976063529378,0.00357075504608852,0.0137226167364401,0.000842451222362375
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,29786,-0.00580186350403974,0.00262982404417279,-0.0109563186306184,-0.000647408377461076,0.0273790522041272
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,29786,0.00218467200693926,0.0025803323435633,-0.00287277938644481,0.00724212340032333,0.397189774801659
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,29786,0.00825413949038059,0.00250555533498108,0.00334325103381768,0.0131650279469435,0.00098769854514216
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,29786,0.010383705459194,0.00244692403832466,0.00558773434407771,0.0151796765743104,2.20651935778819e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,29786,0.00391058131106546,0.00259547035994945,-0.00117654059443546,0.00899770321656639,0.131899552777904
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,29786,-0.00664303532040051,0.00252964931710024,-0.011601147981917,-0.00168492265888404,0.00864213305716088
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,29786,-0.00731063784856834,0.00252334473250161,-0.0122563935242715,-0.00236488217286518,0.00376782322241861
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,29786,0.00640571754154769,0.00263600298156908,0.0012391516976723,0.0115722833854231,0.0151010529195975
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,29786,0.00689282180972791,0.00266195818356285,0.00167538376994473,0.0121102598495111,0.0096195659589992
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,29786,0.00119508045427401,0.00244444482280104,-0.00359603139841603,0.00598619230696404,0.624918593602267
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,29786,-0.0053132107266045,0.00261840398425395,-0.0104452825357423,-0.00018113891746675,0.0424489267830323
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,29786,0.00364962512122494,0.00240597555221804,-0.00106608696112241,0.00836533720357229,0.12930246640573
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,29786,-0.00132917357467367,0.00253154888000517,-0.00629100937948379,0.00363266223013646,0.59955678151766
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,29786,-5.6880519749372e-05,0.00251168479129466,-0.00497978271068692,0.00486602167118817,0.981932514574224
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,29786,-0.00486363994652706,0.00246355390426896,-0.00969220559889421,-3.50742941599017e-05,0.048363997386961
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,29786,-0.00105550050994036,0.00258506586035699,-0.00612222959624006,0.00401122857635933,0.683051230490132
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,29786,-0.0129897744940729,0.0024219316997675,-0.0177367606256172,-0.00824278836252862,8.228077810394e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,29786,0.0082682097859963,0.00257345757263738,0.00322423294362704,0.0133121866283656,0.00131551090517034
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,29786,0.0108351446150102,0.0024084963117687,0.00611449184394359,0.0155557973860769,6.86229520815755e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,29786,-0.0036021167296179,0.00265596072986195,-0.00880779976014732,0.00160356630091153,0.175033517315708
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,29786,-0.00296115833080507,0.0025449593063548,-0.00794927857126048,0.00202696190965034,0.244620380600863
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,29786,-0.0228692669079781,0.00242693428493893,-0.0276260581064584,-0.0181124757094978,4.68531488934427e-21
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,29786,0.013773266991108,0.00245329802904703,0.0089648028541758,0.0185817311280402,1.99249053485734e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,29786,0.0248323816111881,0.00247302055678766,0.0199852613198843,0.029679501902492,1.0943014863557e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,29786,-0.0168931578879644,0.00263488172155553,-0.0220575260622132,-0.0117287897137155,1.4639244841925e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,29786,-0.00157482286259036,0.0024939853952023,-0.00646303423718688,0.00331338851200615,0.527752284854074
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,29786,-0.0251290865086866,0.00243518536245713,-0.0299020498191026,-0.0203561231982706,6.35859385803172e-25
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,29786,0.0142194270128454,0.00242992751437432,0.00945676908467172,0.018982084941019,4.91396099341502e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,29786,0.027856215315928,0.00243206436851982,0.0230893691536291,0.0326230614782268,2.6071324120962e-30
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,29786,-0.0161521289589285,0.00254548059629013,-0.0211412709276572,-0.0111629869901999,2.25015855171939e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,29786,0.00828474546994238,0.00255521132509648,0.00327653127275327,0.0132929596671315,0.00118702237630094
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,29772,-0.000179455690858943,0.00272644226169874,-0.00552328252378847,0.00516437114207058,0.947521206932118
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,29772,-0.0129685554297585,0.00254372697131534,-0.0179542602935366,-0.00798285056598044,3.44906716651792e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,29772,-0.0104407849989661,0.00244349846764872,-0.0152300419955576,-0.00565152800237465,1.93560167324778e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,29772,-0.00466929132341129,0.00287173324829616,-0.0102978884900718,0.00095930584324918,0.103971129524405
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,29772,0.01835692743696,0.00268775352399028,0.0130889305299391,0.023624924343981,8.66430131960711e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,29786,-0.0179396335030184,0.00267332515983558,-0.0231793508162962,-0.0126999161897407,1.97289919597194e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,29786,-0.00212394548398745,0.00274283042942311,-0.00749989312565674,0.00325200215768183,0.438722504225865
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,29786,-0.00499935278827438,0.00270020433873331,-0.0102917532921917,0.000293047715642905,0.0641115712566006
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,29786,0.00962156311732755,0.00264809258011218,0.00443130166030768,0.0148118245743474,0.000280187822663181
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,29786,0.021437826516748,0.00264021539108194,0.0162630043502274,0.0266126486832686,4.85111855472387e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,29786,0.00533867721604215,0.00270574315298202,3.54206361973947e-05,0.0106419337958869,0.0484944408551673
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,29786,-0.0175860057443062,0.00266053119304509,-0.0228006468826746,-0.0123713646059378,3.90912427918202e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,29786,-0.0207303320444746,0.00258735270737495,-0.0258015433509295,-0.0156591207380197,1.16781062586671e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,29786,0.00600660515281966,0.00282554619856913,0.000468534603624168,0.0115446757020151,0.0335263820626058
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,29786,0.0239692078144724,0.00259872240479074,0.0188757119010826,0.0290627037278623,3.06092409191586e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,29786,-0.00262542643522145,0.00248622434190424,-0.00749842614535377,0.00224757327491087,0.290981647740668
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,29786,-0.0111773999073802,0.00248454550081143,-0.0160471090889706,-0.00630769072578975,6.86058877725228e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,29786,-0.0160182565113068,0.00246872243085231,-0.0208569524757773,-0.0111795605468363,8.8067065138881e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,29786,0.0185566642006645,0.00258703775065069,0.0134860702093891,0.0236272581919398,7.51168605565804e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,29786,0.0214658528635132,0.00264441644704541,0.0162827966273042,0.0266489090997222,4.94375186400536e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51313,0.000268693447946771,0.00209459183210804,-0.00383670654298499,0.00437409343887853,0.897928194198567
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51313,-0.000727155179928333,0.00204418008255451,-0.00473374814173518,0.00327943778187851,0.722051933125041
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,47858,-0.000121411495038637,0.00195661880023361,-0.00395638434349652,0.00371356135341924,0.950521931148098
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,47858,-0.00138391189191791,0.00213065838166728,-0.00556000231998577,0.00279217853614995,0.516003421924103
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,47858,-0.000203982897280996,0.0020997364128982,-0.00431946626656146,0.00391150047199947,0.922610137801049
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,47858,-0.000299076247195954,0.0019268716778999,-0.00407574473587977,0.00347759224148786,0.8766537628484
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24009.Traffic intensity on the nearest road,51313,0.0281873155588459,0.0439012421358363,-0.0578591190273933,0.114233750145085,0.52083585257706
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24010.Inverse distance to the nearest road,51313,0.00229313240551534,0.00183058344758563,-0.00129481115175249,0.00588107596278316,0.21032846802118
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24011.Traffic intensity on the nearest major road,51313,-0.000779955287274847,0.00183089168262965,-0.00436850298522897,0.00280859241067927,0.670111451916657
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24012.Inverse distance to the nearest major road,51313,0.00228352837143764,0.00185831242585768,-0.0013587639832434,0.00592582072611869,0.219145564372388
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24013.Total traffic load on major roads,51313,0.0113246427731318,0.0306154395366696,-0.0486816187187405,0.0713309042650042,0.711458730748621
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24015.Sum of road length of major roads within 100m,51313,0.0107070606653757,0.0296945570642216,-0.0474942711804986,0.0689083925112499,0.718420031429269
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51313,-0.00103001434632315,0.00209198733597879,-0.00513030952484159,0.00307028083219529,0.622465808757525
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51313,-0.000563417774703039,0.00208936293855996,-0.00465856913428055,0.00353173358487447,0.787422860198228
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51313,-7.42559556098044e-05,0.00206735315881034,-0.00412626814687807,0.00397775623565846,0.971347587957694
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51210,-0.00335802709214726,0.0020298222911222,-0.00733647878274676,0.000620424598452241,0.0980634914259018
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24020.Average daytime sound level of noise pollution,51313,0.00162327034975355,0.00183623450399798,-0.00197574927808249,0.0052222899775896,0.376688876486125
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24021.Average evening sound level of noise pollution,51313,0.00160597665294993,0.00183616171315138,-0.00199290030482677,0.00520485361072664,0.381775045538303
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24022.Average night-time sound level of noise pollution,51313,0.00161838583667866,0.00183624780266529,-0.00198065985654532,0.00521743152990263,0.378129936982447
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51313,0.00161322762617108,0.00183616717218727,-0.00198566003131597,0.00521211528365813,0.379630833467303
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51313,0.00161853574797233,0.00183617979390861,-0.00198037664808855,0.00521744814403321,0.378068102150656
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2405.Number of children fathered,23634,-0.0434130762967773,0.0334967871157069,-0.109066779043563,0.0222406264500081,0.194975393106057
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",45790,0.000548822475227316,0.00216028181069395,-0.00368532987373283,0.00478297482418746,0.799457041189051
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",45790,0.00129160982130964,0.00195730227270749,-0.00254470263319704,0.00512792227581631,0.509325897779067
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24502.Water percentage, buffer 1000m",45790,0.00501849607934605,0.00194527278750708,0.00120576141583216,0.00883123074285993,0.00988764558703023
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24503.Greenspace percentage, buffer 300m",45790,0.000584120538295508,0.00203301906316508,-0.00340059682550805,0.00456883790209906,0.773871058187786
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",45790,-0.000266631710488536,0.00197422881801648,-0.00413612019380084,0.00360285677282377,0.892568086656866
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24505.Water percentage, buffer 300m",45790,0.0035636782180504,0.00195669591268913,-0.000271445770820293,0.00739880220692108,0.0685718318414204
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51550,-0.000498890850702278,0.00206322508678303,-0.00454281202079701,0.00354503031939245,0.808934964974781
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51550,-0.000768813991034105,0.00193893594566539,-0.00456912844453827,0.00303150046247006,0.691728001650686
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24508.Distance (Euclidean) to coast,51550,0.000155416361960856,0.00184439616580257,-0.00345960012301217,0.00377043284693389,0.932846791250398
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,11314,-0.0347185759332254,0.0452722412416709,-0.1234521687669,0.0540150169004497,0.443166265978878
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2704.Years since last cervical smear test,21299,0.0862435243900178,0.0325861584750504,0.0223746537789191,0.150112395001117,0.00813579276320362
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2714.Age when periods started (menarche),27158,0.0654414160819395,0.0276093895566344,0.0113270125509361,0.119555819612943,0.0177825545080273
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2734.Number of live births,28000,-0.0186163709710198,0.0265410969585014,-0.0706369210096826,0.0334041790676431,0.483048782084457
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2744.Birth weight of first child,22206,0.104918212732364,0.029714584454679,0.0466776272011934,0.163158798263535,0.000415041345873114
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2754.Age at first live birth,18914,0.00851813153285524,0.00316118955159497,0.00232220001172909,0.0147140630539814,0.00705361106286245
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2764.Age at last live birth,18860,0.00686953770034577,0.00305522375139542,0.000881299147610738,0.0128577762530808,0.0245586014432289
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2794.Age started oral contraceptive pill,21488,0.000674732791121551,0.00344848423849036,-0.00608429631631956,0.00743376189856266,0.844877608936729
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2804.Age when last used oral contraceptive pill,19488,-0.0177323240612383,0.00296742032301652,-0.0235484678943507,-0.011916180228126,2.33134697213773e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2867.Age started smoking in former smokers,12715,0.0050650070806473,0.00374857276128832,-0.00228219553147781,0.0124122096927724,0.176660946755805
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",19794,-0.017643851713178,0.0392070629776452,-0.0944896951493626,0.0592019917230065,0.652702988846511
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,19785,0.0237739954005575,0.0433093061311782,-0.0611122446165518,0.108660235417667,0.583056234668509
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,19824,0.0266043083504666,0.04462867392663,-0.0608678925457282,0.114076509246661,0.551097935698027
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",19768,0.033388706717972,0.0436250162481321,-0.0521163251283669,0.118893738564311,0.444068201580304
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28739.Difficulty with standing for long periods,19843,-0.131634287445933,0.03800225477339,-0.206118706801777,-0.0571498680900886,0.000533618687066925
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28740.Difficulty with taking care of household responsibilities,19889,-0.109089973512988,0.0422521434451301,-0.191904174665443,-0.0262757723605327,0.00983345891012616
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28741.Difficulty learning a new task,19730,-0.103318202817408,0.0478610126959435,-0.197125787701458,-0.00951061793335918,0.0308844487778471
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28742.Difficulty with joining in community activities,19019,-0.0894014410464104,0.047815495347215,-0.183119811926952,0.00431692983413108,0.0615385035593814
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28743.Difficulty with being emotionally affected by health problems,19756,-0.0504500237253763,0.0408954855018947,-0.13060517530909,0.0297051278583374,0.217354349585943
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,19889,-0.111622317291706,0.0575462541621117,-0.224412975449445,0.00116834086603246,0.0524306127217192
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,12075,-0.0631413954549639,0.0434466221249084,-0.148296774819784,0.0220139839098566,0.14616381702846
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2897.Age stopped smoking,12721,-0.00930919057544727,0.00391043131678659,-0.016973635956349,-0.00164474519454556,0.0172989077805767
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,17760,0.00754908779459052,0.00654306050593008,-0.00527531079703244,0.0203734863862135,0.248616227586117
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,17760,-0.0103275510584614,0.00712769915140011,-0.0242978413952056,0.00364273927828283,0.147374255792368
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,17760,0.0493676031023959,0.023791144083584,0.00273696069857135,0.0959982455062205,0.0379970948052449
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,17760,-0.00091593585684472,0.0244836358490021,-0.0489038621208888,0.0470719904071994,0.970158421208881
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,17760,0.01300712100544,0.027148877809165,-0.0402046795005234,0.0662189215114035,0.631870939373378
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,17760,-0.00163386212809495,0.0231727753082943,-0.0470525017323517,0.0437847774761618,0.943790262218959
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,17760,-0.00201197030045317,0.0102811501563717,-0.0221630246069418,0.0181390840060354,0.844851091504661
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,17760,0.000424546283141519,0.0184997201889587,-0.0358349052872176,0.0366839978535006,0.981691375997304
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29002.Recent lack of interest or pleasure in doing things,17640,-0.0327607129852582,0.0454037119165475,-0.121751988341691,0.0562305623711749,0.470585303816081
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29003.Recent feelings of depression,17624,-0.0163872917665321,0.0440164361349315,-0.102659506590998,0.0698849230579336,0.709674442738621
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",17648,-0.0281537185874957,0.0353634320185357,-0.0974660453438258,0.0411586081688343,0.425969999827329
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29005.Recent feelings of tiredness or low energy,17658,-0.04635511705776,0.035633574562339,-0.116196923199944,0.0234866890844244,0.193315441963281
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29006.Recent poor appetite or overeating,17671,0.037776550458567,0.0497314951198403,-0.05969717997632,0.135250280893454,0.44749776857075
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29007.Recent feelings of inadequacy,17600,0.0332373883678469,0.0479201731652474,-0.0606861510360381,0.127160927771732,0.487942828092611
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29008.Recent trouble concentrating on things,17667,-0.0471041901163943,0.0471264582548612,-0.139472048295922,0.0452636680631336,0.317552935271043
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29009.Recent changes in speed or amount of moving or speaking,17651,0.0749689849034019,0.0825231936688516,-0.0867764746875473,0.236714444494351,0.363647880350765
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29010.Recent thoughts of suicide or self-harm,17565,0.1768876946265,0.0914086614040994,-0.00227328172553515,0.356048670978535,0.0529903228039143
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#0.Substances taken for depression_None of options listed,16249,0.022455033432624,0.0126844527793623,-0.00240649401492616,0.0473165608801742,0.0766992668073505
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),16249,0.0415124372128538,0.024519609664731,-0.00654599773001893,0.0895708721557266,0.0904689233478149
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),16249,0.0168678801217099,0.0126566349787144,-0.00793912443657022,0.0416748846799901,0.18263905041317
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),16249,0.0560283800572355,0.0370443718270494,-0.0165785887237813,0.128635348838252,0.130434633866718
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),16249,0.0374123108945512,0.023591043783526,-0.00882613492115977,0.0836507567102621,0.11278844845227
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),16249,-0.00421457285830981,0.0253481049006266,-0.0538968584635379,0.0454677127469183,0.867948299808931
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),16249,-0.00934526795606637,0.0283909056584372,-0.0649914430466033,0.0463009071344706,0.742035874523499
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),16249,0.0144917129105012,0.0330057836453394,-0.0501996230343639,0.0791830488553663,0.660619656021584
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),16249,0.0374358896661297,0.0247994372740686,-0.0111710073910447,0.0860427867233041,0.131178786971338
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,16249,0.0319742433807675,0.0124532172226083,0.00756593762445525,0.0563825491370797,0.0102509055699297
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,16249,0.0305438412332725,0.0193981083771966,-0.0074764511860328,0.0685641336525777,0.115373291668281
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,16249,-0.0322731606905572,0.0303133032990223,-0.091687235156641,0.0271409137755266,0.287048649931011
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,16249,0.0895296644496849,0.0392657429215099,0.0125688083235255,0.166490520575844,0.0226149004701458
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,16249,0.0195476845631378,0.024336685190338,-0.0281522184099247,0.0672475875362003,0.42186000472901
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,16249,0.0638894428540143,0.0396140256926709,-0.0137540475036208,0.141532933211649,0.106807719554955
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,16249,-0.0137862033354206,0.0387674224852177,-0.0897703514064473,0.0621979447356062,0.722134951041126
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,16249,0.0264178985874221,0.0209841108380168,-0.0147109586550908,0.067546755829935,0.208067315727254
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,16249,-0.00280299225345312,0.0202666325715974,-0.042525592093784,0.0369196075868777,0.890000479653376
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,16249,0.0400835916681807,0.0290553368161889,-0.0168648684915496,0.0970320518279111,0.167741042095947
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29058.Recent feelings or nervousness or anxiety,17381,0.00324806167797098,0.0416573176513776,-0.0784002809187291,0.0848964042746711,0.93785203953971
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29059.Recent inability to stop or control worrying,17401,-0.0183785020387106,0.0433128410886161,-0.103271670572398,0.0665146664949769,0.671337751069087
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29060.Recent worrying too much about different things,17389,-0.0102545309933601,0.0398675467213491,-0.0883949225672045,0.0678858605804842,0.797015852026116
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29061.Recent trouble relaxing,17392,-0.0151770399288048,0.042242995095776,-0.0979733103165258,0.0676192304589161,0.719390413739661
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29062.Recent restlessness,17413,-0.0440302165760729,0.0598740703839143,-0.161383394528545,0.073322961376399,0.462117781416187
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29063.Recent easy annoyance or irritability,17366,-0.0343485877222707,0.042579400300587,-0.117804212311421,0.0491070368668798,0.419853304713976
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29064.Recent feelings of foreboding,17356,-0.000463337477733503,0.0487218474808991,-0.0959581585402958,0.0950314835848288,0.992412461008596
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,16249,0.0145576782794371,0.013319302992363,-0.0115481555855943,0.0406635121444685,0.274420562331245
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,16249,0.00608292162833627,0.0223453124222971,-0.037713890719366,0.0498797339760386,0.78545355029251
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',16249,0.0127096728762169,0.0288058428792594,-0.0437497791671316,0.0691691249195655,0.659060644476129
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,16249,0.0520440715786707,0.0307037599492692,-0.00813529792189695,0.112223441079238,0.0900871930552148
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#2.Symptoms of panic attack_Sweating,16249,0.0181100749657199,0.0200852585380968,-0.0212570317689498,0.0574771817003896,0.367250863587942
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,16249,0.00473636202032577,0.0216623388136127,-0.0377218220543552,0.0471945460950067,0.826929345953079
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,16249,0.0205138985188864,0.021684054189145,-0.0219868476918377,0.0630146447296105,0.344144242563677
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,16249,0.0124565289164387,0.0200245954846492,-0.0267916782334736,0.0517047360663511,0.533910197450733
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,16249,-0.00445637512403972,0.0266703773856081,-0.0567303147998316,0.0478175645517521,0.867300673096663
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29076.Felt loved as a child,17328,-0.0117107652819893,0.0369577325402108,-0.0841479210608025,0.060726390496824,0.751346712777675
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29077.Physically abused by family as a child,17354,-0.0238327692119519,0.0496191942732606,-0.121086389987543,0.073420851563639,0.631010546145235
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29078.Felt hated by family member as a child,17325,-0.0687177070378986,0.0502911203124441,-0.167288302850289,0.0298528887744919,0.171831696989103
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29079.Sexually molested as a child,17198,-0.109863817798697,0.0674578754949605,-0.24208125376882,0.0223536181714257,0.103410023974309
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29080.Someone to take to doctor when needed as a child,17295,0.0735194618434905,0.053645621724588,-0.031625956736702,0.178664880423683,0.17055951161061
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,17332,-0.0965815154600759,0.0695118908489026,-0.232824821523925,0.0396617906037731,0.164721606521517
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29082.Belittlement by partner or ex-partner as an adult,17223,-0.0306537038562987,0.0544064382456673,-0.137290322817807,0.0759829151052092,0.573155907235013
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29083.Physical violence by partner or ex-partner as an adult,17345,0.0166094023539222,0.0611443861976594,-0.10323359459349,0.136452399301335,0.785900298761966
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,17294,0.10610734892084,0.0856768996397393,-0.0618193743730494,0.274034072214729,0.215562647444981
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,17293,-0.0864324255848545,0.0819952773292576,-0.247143169150199,0.0742783179804903,0.291845155815218
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29086.Experienced a violent or sexual assault,17346,0.0621992992163211,0.0693689730584594,-0.0737638879782593,0.198162486410902,0.369921167699203
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29087.Experienced a life-threatening injury or illness,17347,-0.0905388792025208,0.043402393025731,-0.175607569532954,-0.00547018887208803,0.0369901046005316
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29088.Experienced a marital separation or divorce,17354,0.0543210497727406,0.0404562619430777,-0.0249732236356918,0.133615323181173,0.179383293918443
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29089.Experienced the death of a spouse or partner,17373,0.0425586129073266,0.0549973861461018,-0.0652362639390329,0.150353489753686,0.43904202289195
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,17350,0.0296417759367313,0.0505732348044665,-0.0694817642800231,0.128765316153486,0.55780527775503
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29091.Frequency of drinking alcohol,17359,0.113514700940117,0.033646282752986,0.0475679867442644,0.17946141513597,0.000743095527709984
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,15478,0.0435562268502396,0.0386702492794488,-0.0322374617374801,0.119349915437959,0.260034975905611
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,15516,0.105247722052043,0.0391250749286065,0.028562575191974,0.181932868912112,0.00715215964925491
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29104.Ever used cannabis,17346,0.0182981951056315,0.0480396409064448,-0.0758595010710004,0.112455891282263,0.703283729948291
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29108.Ever thought that life not worth living,17263,0.024805382466896,0.0423770646566515,-0.0582536642601408,0.107864429193933,0.558320572064944
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29109.Ever contemplated self-harm,17307,0.0688296796387761,0.0570388552484408,-0.0429664766481678,0.18062583592572,0.227558175325904
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29111.Ever self-harmed,17334,0.00730211291049096,0.091934001083211,-0.172888529212603,0.187492755033585,0.936693296939765
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,17329,-0.082067875892928,0.0611170656418963,-0.201857324551045,0.0377215727651887,0.179354981574547
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,17581,0.0760603197575014,0.0284526864013967,0.0202930544107638,0.131827585104239,0.00751961539037045
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,17581,0.0342678789052929,0.0219120075374523,-0.00867965586811366,0.0772154136786994,0.117862386883676
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,17581,0.00525365847509657,0.0235694872976779,-0.0409425366283521,0.0514498535785452,0.823615275552489
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,17581,0.05562286864655,0.0318598848597591,-0.0068225056785778,0.118068242971678,0.0808529262254026
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,17312,-0.00788457308911787,0.0378186152524802,-0.0820090589839791,0.0662399128057434,0.834853592986734
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X29153.Pain or discomfort today,17340,-0.0537070992028509,0.0357909138388067,-0.123857290326912,0.0164430919212102,0.133482671478949
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29154.Anxiety or depression today,17340,0.0441363875615988,0.0447918681499149,-0.0436556740122343,0.131928449135432,0.324458046689498
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29166.Frequency of confiding in someone close,16913,-0.070421295574957,0.0349592553923893,-0.13894143614404,-0.00190115500587391,0.0439852567379491
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,17285,-0.02795127287303,0.00662505743879249,-0.0409363854530633,-0.0149661602929967,2.46614409345483e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,17285,0.0194994246492466,0.00665472486981462,0.00645616390440992,0.0325426853940832,0.00339228330474303
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,17285,0.0132048785442692,0.00830083234847062,-0.00306475285873327,0.0294745099472716,0.111675215621045
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,17285,0.0131162038536828,0.00897665599057826,-0.00447804188785063,0.0307104495952161,0.143993605595817
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,17285,-0.00881163652037424,0.014517055686194,-0.0372650656653145,0.019641792624566,0.543868778494141
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,17285,0.00932039717826155,0.00684635237236306,-0.00409845347157004,0.0227392478280931,0.173415545822307
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,17283,-0.00886400986632289,0.00745474440414438,-0.0234753088984459,0.0057472891658001,0.23443919004103
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,17283,0.0109013278535424,0.010880754543265,-0.0104249510512571,0.0322276067583419,0.316410375472269
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,17283,0.0170247218501899,0.0168524851768872,-0.0160061490965091,0.0500555927968889,0.312403931879554
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,17283,0.0120757506840296,0.0150794709046882,-0.0174800122891592,0.0416315136572184,0.423254217679925
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,17283,-0.00791326534538948,0.0223079379846368,-0.0516368237952775,0.0358102931044986,0.722797196205553
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,17283,0.00798142053236413,0.0107194620454192,-0.0130287250766574,0.0289915661413857,0.456540110737182
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29171.Frequency of feeling 'in tune' with people,16992,0.0189337309382297,0.0433618784607816,-0.0660555508449021,0.103923012721362,0.662374650962815
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29172.Freuency of feeling that lacks companionship,17215,0.116771742082458,0.0395918183984036,0.0391717780215873,0.194371706143329,0.00318829709824619
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29173.Frequency of feeling left out,17126,0.0602239159336502,0.0412282388265749,-0.0205834321664366,0.141031264033737,0.144103980744187
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29174.Frequency of feeling isolated from others,17193,0.0472493947586769,0.0425535050920817,-0.0361554752218034,0.130654264739157,0.266862659878355
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29175.Tendency to bounce back quickly after hard times,17318,0.00018079209653462,0.0349155718197416,-0.0682537286701588,0.0686153128632281,0.995868648686551
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29176.Ability to make it through stressful events,17318,0.0158723635217048,0.0339848858384658,-0.0507380127216881,0.0824827397650977,0.640475827149731
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29177.Quick recovery from stressful events,17318,-0.0196129004719033,0.0346025636072327,-0.0874339251420794,0.0482081241982728,0.570854136054676
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29178.Hard to snap back when something bad happens,17318,0.0315793937315062,0.0341057154878533,-0.0352678086246862,0.0984265960876986,0.354496972442095
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29179.Comes through difficult times with little trouble,17318,-0.0117450792364915,0.0346212390679825,-0.0796027078097372,0.0561125493367542,0.734429355014346
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29180.Tendency to take a long time to get over setbacks,17318,0.0403526426387026,0.0343652882889348,-0.0270033224076095,0.107708607685015,0.240320355020708
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29181.General happiness,17218,0.0556454124051015,0.0359094761378078,-0.0147371608250018,0.126027985635205,0.121255361589083
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29182.Belief that own life is meaningful,17024,-0.0220131604611174,0.0356212244948797,-0.0918307604710816,0.0478044395488468,0.536597608904404
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,11577,-0.0413981828937579,0.0415936099141994,-0.122921658325589,0.0401252925380728,0.319610471061048
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2946.Father's age,11357,0.00277440515153996,0.00584740583851823,-0.00868651029195576,0.0142353205950357,0.635175565431978
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2966.Age high blood pressure diagnosed,12987,0.00439764239578086,0.00465935634175876,-0.00473469603406632,0.013529980825628,0.345273873880919
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30000.White blood cell (leukocyte) count,50359,-0.0498542653038346,0.0019341197164455,-0.0536451399480678,-0.0460633906596014,1.44959770972219e-145
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,50360,0.0295375317637179,0.00217005482603219,0.0252842243046949,0.033790839222741,4.06740611264968e-42
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30020.Haemoglobin concentration,50360,0.0227640266624738,0.00232258018491142,0.0182117695000474,0.0273162838249002,1.16599443517662e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30030.Haematocrit percentage,50360,0.0221725499734802,0.00226924693192199,0.0177248259869131,0.0266202739600473,1.57225699021388e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30040.Mean corpuscular volume,50360,-0.0165419819760791,0.00191841064377527,-0.0203020668378786,-0.0127818971142796,6.72297050242317e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30050.Mean corpuscular haemoglobin,50359,-0.0155453629771564,0.00192430648670296,-0.0193170036910942,-0.0117737222632186,6.70535940368263e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,50359,-0.000146412305887437,0.00187829786743064,-0.00382787612605148,0.00353505151427661,0.937868564858164
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,50360,-0.0183308386239101,0.00187383539024248,-0.0220035559887853,-0.0146581212590348,1.40182381516742e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30080.Platelet count,50360,-0.0199391908061433,0.00191773015107042,-0.0236979419022413,-0.0161804397100452,2.70600126551329e-25
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30090.Platelet crit,50360,-0.0167819723328757,0.00196088591692344,-0.0206253087300457,-0.0129386359357058,1.17654737674568e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,50360,0.0113052835381734,0.00184184438889825,0.00769526853593283,0.014915298540414,8.4176520784413e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30110.Platelet distribution width,50360,0.0146493818864467,0.00186343323653798,0.0109970527428323,0.0183017110300611,3.87055401431837e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30120.Lymphocyte count,50283,-0.0237057936864629,0.00191197044470759,-0.0274532557580898,-0.019958331614836,2.99405138207634e-35
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30130.Monocyte count,50283,-0.0198602216225965,0.00192834923473422,-0.0236397861226756,-0.0160806571225174,7.5305980673436e-25
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30140.Neutrophill count,50283,-0.0478398570638786,0.00191120901709787,-0.0515858267373904,-0.0440938873903668,1.95159516422988e-137
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30150.Eosinophill count,50283,0.0135264827598611,0.00187037725253887,0.00986054334488491,0.0171924221748373,4.82857844543164e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30160.Basophill count,50283,-0.215038086955706,0.0221638766147917,-0.258479285120698,-0.171596888790714,3.08668398196604e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30170.Nucleated red blood cell count,50283,0.344600122057948,0.103944091909025,0.140869701916259,0.548330542199636,0.000916276408595352
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30180.Lymphocyte percentage,50284,0.0146687684477109,0.00188341399015425,0.0109772770270086,0.0183602598684133,6.91604592768298e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30190.Monocyte percentage,50284,0.0161405995568225,0.00190740626116097,0.012402083284947,0.019879115828698,2.69648081100153e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30200.Neutrophill percentage,50284,-0.0221830420119578,0.0018624049964366,-0.0258333558049736,-0.0185327282189421,1.14832547726581e-32
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30210.Eosinophill percentage,50284,0.0309730575917552,0.00184650836821186,0.0273539011900599,0.0345922139934504,5.6276637264281e-63
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30220.Basophill percentage,50284,-0.00417650303189984,0.00184297069805353,-0.00778872560008475,-0.000564280463714926,0.0234446068842218
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30230.Nucleated red blood cell percentage,50282,0.342027530931673,0.104088371506671,0.138014322778597,0.546040739084748,0.00101714366073969
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30240.Reticulocyte percentage,49482,-0.00774353802538154,0.00198654617853528,-0.0116371685353107,-0.00384990751545239,9.71220482615467e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30250.Reticulocyte count,49482,-0.00176120914718831,0.00202948649893997,-0.00573900268511065,0.00221658439073402,0.38550243801855
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30260.Mean reticulocyte volume,49482,-0.0183524105606578,0.00189076777045391,-0.0220583153907475,-0.0146465057305681,2.96628490327878e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30270.Mean sphered cell volume,49482,-0.0197528305016878,0.00190684246646566,-0.0234902417359605,-0.0160154192674151,4.04484163158166e-25
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30280.Immature reticulocyte fraction,49482,-0.0159991445632777,0.00198416283148847,-0.0198881037129951,-0.0121101854135603,7.58372151193091e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30290.High light scatter reticulocyte percentage,49482,-0.0130652723989785,0.00202790647643681,-0.0170399690927947,-0.00909057570516239,1.18411032581112e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30300.High light scatter reticulocyte count,49482,-0.00831271934653509,0.00205919810267582,-0.0123487476277797,-0.00427669106529049,5.42500692237001e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30500.Microalbumin in urine,16359,-0.0104160037841275,0.0033749796024936,-0.017030963805015,-0.00380104376324007,0.00203042650715776
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,50465,0.0139906791500523,0.00201366817390498,0.0100438895291986,0.0179374687709061,3.7535828206983e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30520.Potassium in urine,50364,0.0173670978241059,0.00187471561777254,0.0136926552132717,0.0210415404349401,2.04686150155177e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30530.Sodium in urine,50346,0.0108499182664887,0.00196059581488,0.0070071504693239,0.0146926860636535,3.14581729644782e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30600.Albumin,45398,-0.000306688327807986,0.0020230817996592,-0.00427192865514001,0.00365855199952404,0.87950734644094
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30610.Alkaline phosphatase,49537,0.0441155524205348,0.00192400796790597,0.0403444968034391,0.0478866080376305,9.59623323628016e-116
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30620.Alanine aminotransferase,49531,-0.001332266789024,0.00204469250775149,-0.00533986410421692,0.00267533052616892,0.514679581326289
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30630.Apolipoprotein A,45115,0.00786032147234369,0.00221682932019451,0.00351533600476245,0.0122053069399249,0.000391894577438832
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30640.Apolipoprotein B,49269,0.0176950823092302,0.00187190911991429,0.0140261404341982,0.0213640241842622,3.43297518375882e-21
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30650.Aspartate aminotransferase,49384,0.0111002237973775,0.00194147508868393,0.00729493262355696,0.014905514971198,1.08777211613139e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30660.Direct bilirubin,42038,0.00824420954379119,0.00212005800415429,0.00408889585564877,0.0123995232319336,0.000100949300572984
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30670.Urea,49515,0.0185292749853575,0.00197460202648659,0.0146590550134438,0.0223994949572712,6.62324065988995e-21
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30680.Calcium,45397,-0.00475278736602874,0.00196217887667634,-0.00859865796431437,-0.000906916767743109,0.0154307977161706
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30690.Cholesterol,49548,0.0269712817124017,0.00189649215713885,0.0232541570844095,0.0306884063403938,8.27704279408798e-46
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30700.Creatinine,49528,0.0102164085661687,0.00229232070350894,0.0057234599872912,0.0147093571450462,8.33754918161456e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30710.C-reactive protein,49399,4.88413843195781e-06,0.00209614877071388,-0.00410356745216724,0.00411333572903116,0.998140897512441
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30720.Cystatin C,49548,0.0434916446755023,0.00218431231668954,0.0392103925347908,0.0477728968162138,7.23385812075932e-88
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30730.Gamma glutamyltransferase,49528,-0.014604703004986,0.00208380544722582,-0.0186889616815486,-0.0105204443284234,2.43662448178678e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30740.Glucose,45345,-0.00996190841526526,0.00201533144326097,-0.0139119580440567,-0.00601185878647377,7.71789953869982e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),49253,-0.030524004395795,0.00202443732682861,-0.0344919015563791,-0.026556107235211,2.9528605223287e-51
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30760.HDL cholesterol,45369,0.00618381482856745,0.00231300376941331,0.00165032744051737,0.0107173022166175,0.00750912217327391
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30770.IGF-1,49290,-0.0388980738901854,0.00195000417201969,-0.042720082067344,-0.0350760657130268,3.50426134000745e-88
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30780.LDL direct,49439,0.0246025155727754,0.00187139846995727,0.0209345745716591,0.0282704565738916,2.07337628313744e-39
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30790.Lipoprotein A,39595,-0.000213079830668629,0.00209248113271589,-0.00431434285079177,0.00388818318945451,0.918891189091505
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30810.Phosphate,45296,0.00481635915788643,0.00203117734960966,0.000835251552651498,0.00879746676312136,0.0177338510525065
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30830.SHBG,44972,-0.0209729697727096,0.00233251600521676,-0.0255447011429345,-0.0164012384024848,2.52971174055982e-19
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30840.Total bilirubin,49350,0.0207224499799168,0.00198666808295421,0.0168285805373266,0.024616319422507,1.90741014246618e-25
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30850.Testosterone,44763,-0.025991713952532,0.00322848602030489,-0.0323195465523296,-0.0196638813527344,8.43051933228555e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30860.Total protein,45362,-0.0210151694256003,0.00199137692832275,-0.0249182682051129,-0.0171120706460877,5.26932952784876e-26
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30870.Triglycerides,49509,0.022292499667011,0.00203791257046334,0.0182981910289028,0.0262868083051191,8.08360937292496e-28
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30880.Urate,49477,0.0194884216594602,0.00234276194674794,0.0148966082438342,0.0240802350750862,9.12757397333088e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30890.Vitamin D,47305,-0.00394822335285571,0.00211435311786599,-0.00809235546387305,0.000195908758161634,0.0618598290221316
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3137.Number of measurements made,47085,-0.0021087217615211,0.0256233945051991,-0.0523305749917112,0.0481131314686691,0.934411098955529
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3143.Ankle spacing width,29455,0.0135847730682826,0.00331595558237087,0.00708550012683569,0.0200840460097295,4.20039092992387e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",29453,-0.0060033720961524,0.00255362878409732,-0.0110084845129832,-0.000998259679321649,0.0187337141959981
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3146.Speed of sound through heel,29455,-0.0079104348853993,0.00246612018001068,-0.0127440304382202,-0.00307683933257837,0.0013397029218146
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",29455,-0.00759318350369573,0.00249202317211611,-0.0124775489210433,-0.00270881808634816,0.0023134579828829
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3148.Heel bone mineral density (BMD),29433,-0.0074714755921755,0.00249558251140993,-0.012362817314539,-0.00258013386981203,0.0027568277791157
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X3526.Mother's age at death,30954,0.0079712847288157,0.00246950259428484,0.00313105964401741,0.012811509813614,0.00124836442461147
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X3581.Age at menopause (last menstrual period),15996,0.0114093377600079,0.00330666193080661,0.00492828037562699,0.0178903951443889,0.000561182242600849
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",10235,0.00136423636054494,0.00428593688956805,-0.00703619994300845,0.00976467266409832,0.750259879588221
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4100.Ankle spacing width (left),16702,0.0171802280188906,0.0045010009437975,0.00835826616904751,0.0260021898687337,0.000135583307594549
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4101.Heel broadband ultrasound attenuation (left),16698,-0.00595505297711403,0.00346809163795516,-0.0127525125875061,0.000842406633278084,0.0859798391810101
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4103.Speed of sound through heel (left),16702,-0.0062963601885408,0.00335649837389503,-0.0128750970013751,0.00028237662429346,0.0606903465886712
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",16702,-0.00663613580933764,0.00339100068994384,-0.0132824971616276,1.02255429522725e-05,0.0503659384710115
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4105.Heel bone mineral density (BMD) (left),16689,-0.00649617118032338,0.00339449511382618,-0.0131493816034227,0.000157039242775927,0.055670859668194
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",16702,-0.00662957781744716,0.00339101038433844,-0.0132759581707505,1.68025358561813e-05,0.0505944307589339
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4119.Ankle spacing width (right),16694,0.0169673863123141,0.00442702163869441,0.00829042390047306,0.0256443487241552,0.000127216528582301
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4120.Heel broadband ultrasound attenuation (right),16693,-0.00411990550361485,0.00348171795755712,-0.0109440727004268,0.0027042616931971,0.236708430278737
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4122.Speed of sound through heel (right),16694,-0.00498694640617793,0.00336014474967213,-0.0115728301155353,0.00159893730317944,0.137789007392202
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",16694,-0.00494381871623356,0.00339795252786596,-0.0116038056708508,0.00171616823838372,0.145704555023972
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4124.Heel bone mineral density (BMD) (right),16679,-0.00533328103625092,0.00340421959807877,-0.0120055514484853,0.00133898937598347,0.117211360942948
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",16694,-0.00494311624772662,0.00339795950926653,-0.011603116885889,0.00171688439043578,0.145762628304795
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4194.Pulse rate,17354,-0.025039707022955,0.00323538892400738,-0.0313810693140095,-0.0186983447319005,1.05424485272625e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4195.Pulse wave reflection index,17354,0.0163607394293605,0.00331920929634655,0.00985508920852128,0.0228663896501998,8.33689331990901e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4196.Pulse wave peak to peak time,17343,0.00357054725186698,0.00330965192933086,-0.00291637052962151,0.0100574650333555,0.28067914598866
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4198.Position of the pulse wave peak,17354,-0.00529395837020629,0.00334240314752283,-0.011845068539351,0.00125715179893846,0.113239751302887
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4199.Position of pulse wave notch,17354,-0.0207790931952522,0.00323446094098334,-0.0271186366395795,-0.0144395497509248,1.35940883005499e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4200.Position of the shoulder on the pulse waveform,17354,-0.0100593312398653,0.00335989395963593,-0.0166447234007517,-0.00347393907897892,0.00275785667723899
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4269.Number of triplets attempted (left),17025,0.105497836063383,0.106309480654074,-0.102868746018603,0.313864418145369,0.321033502937515
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4270.Volume level set by participant (left),16843,-0.0638967137794264,0.0337625913337651,-0.130071392793606,0.00227796523475306,0.0584375613790848
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4276.Number of triplets attempted (right),17031,0.0495550281494747,0.103887024614217,-0.154063540094391,0.253173596393341,0.633361963572795
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4277.Volume level set by participant (right),16833,-0.0783944382314183,0.0337576072487679,-0.144559348439003,-0.0122295280238332,0.0202300254574848
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X4288.Time to answer,17388,-0.00776536723232773,0.0037437197115818,-0.0151030578670281,-0.000427676597627403,0.0380718658434527
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X4290.Duration screen displayed,17388,-0.0111699243423843,0.00341426675912182,-0.0178618871902631,-0.00447796149450555,0.00107170420400319
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X46.Hand grip strength (left),51799,0.0108830854804231,0.00263732256441889,0.00571393325416208,0.0160522377066841,3.68795583934603e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X47.Hand grip strength (right),51803,0.00758157380160228,0.0026147403718661,0.00245668267274473,0.0127064649304598,0.0037385418806339
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X48.Waist circumference,51948,-0.03102613,0.004074607,-0.03901236,-0.0230399,2.691598e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X4803.Tinnitus,17074,-0.0541772618560423,0.0395615035083716,-0.131717808732451,0.023363285020366,0.170878571460807
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X4825.Noisy workplace,17293,-0.0136357866923406,0.0445920946952541,-0.101036292295039,0.0737647189103574,0.759768738406884
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X4836.Loud music exposure frequency,17185,-0.0653389517402053,0.0566948879733998,-0.176460932168069,0.0457830286876584,0.249145527326168
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X49.Hip circumference,51939,0.0319101658732803,0.00326157763767536,0.0255174737034366,0.038302858043124,1.38424670559512e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X50.Standing height,51895,0.0293196200140243,0.00258990376034751,0.0242434086437432,0.0343958313843054,1.12252782472625e-29
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X5057.Number of older siblings,15263,-0.018405368533405,0.0359091674483319,-0.0887873367321356,0.0519765996653256,0.608271129831124
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X51.Seated height,51661,0.0251507860616987,0.0024074592364257,0.0204321659583044,0.0298694061650931,1.60323506890249e-25
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5181.Ever had eye surgery,11717,0.0303306816734473,0.0814187236094427,-0.12925001660106,0.189911379947955,0.709507179518401
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5186.Duration visual-acuity screen displayed (right),11687,-0.00252512407141654,0.00397092432261993,-0.0103081357437516,0.00525788760091853,0.524851887194781
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5188.Duration visual-acuity screen displayed (left),11685,0.00108481876674866,0.00400399960158506,-0.00676302045235806,0.00893265798585537,0.786446751209608
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5190.Duration at which refractometer first shown (right),11556,0.0017202417753111,0.00402992154829303,-0.00617840445934324,0.00961888800996544,0.669483937973953
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5193.Duration at which refractometer first shown (left),11553,-0.000933664171125468,0.00404782871258464,-0.00886740844779135,0.00700008010554042,0.81758457557519
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5199.logMAR, initial (right)",11646,-0.0663733145221706,0.0422900454708396,-0.149261803645016,0.016515174600675,0.116563702114604
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5200.Final number of letters displayed (right),11646,-0.0219543708089361,0.285701737421908,-0.581929776155876,0.538021034538004,0.938749229452901
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5201.logMAR, final (right)",11533,-0.00794643440132164,0.00403799756675585,-0.0158609096321631,-3.19591704801662e-05,0.0491018139907575
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5202.Number of rounds to result (right),11646,0.00261369817132072,0.0399866671762382,-0.0757601694941061,0.0809875658367476,0.947885118629771
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5206.logMAR, initial (left)",11639,-0.0345479731784296,0.0422986573190658,-0.117453341523799,0.0483573951669394,0.414080687511234
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5207.Final number of letters displayed (left),11639,0.317831711828981,0.249579232374322,-0.171343583624689,0.807007007282652,0.202876711883573
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5208.logMAR, final (left)",11528,-0.0106569131412612,0.00402941492677133,-0.018554566397733,-0.00275925988478944,0.00818551513809989
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5209.Number of rounds to result (left),11633,0.0764405363307711,0.0401879053396156,-0.00232775813487543,0.155208830796418,0.0571856674909096
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",11137,0.00359146576292866,0.00400963560002174,-0.00426742001311395,0.0114503515389713,0.370427709585382
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",11137,-0.000240882530402049,0.00399031020144043,-0.00806189052522529,0.0075801254644212,0.951864530309043
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5256.Corneal hysteresis (right),11137,-0.00592855931738021,0.00403811066600922,-0.0138432562227583,0.00198613758799787,0.142091278862503
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5257.Corneal resistance factor (right),11137,-0.00495388121294132,0.00401749255711155,-0.01282816662488,0.00292040419899731,0.217572767344755
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",11109,-0.00513950343904032,0.00400795883546107,-0.012995102756544,0.00271609587846338,0.199755660606578
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",11109,-0.00526343034177042,0.00397467538207798,-0.0130537940906433,0.00252693340710243,0.185450109653047
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5264.Corneal hysteresis (left),11109,0.000404538148796557,0.00404776521081653,-0.00752908166440384,0.00833815796199695,0.920392884209573
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5265.Corneal resistance factor (left),11109,-0.00227541631122763,0.00401043502273882,-0.0101358689557957,0.00558503633334047,0.570471632133357
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,11628,0.0333042310226511,0.188698397203495,-0.336544627496198,0.403153089541501,0.859908539562383
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51784,-0.00456971977265856,0.0105450906819441,-0.0252380975092689,0.0160986579639518,0.664761998945511
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51784,-0.0105431153141219,0.0114640214587745,-0.0330125973733199,0.0119263667450762,0.357749578705409
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51784,0.000842892464684985,0.010944130405636,-0.0206076031303616,0.0222933880597316,0.938609710073486
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51784,-0.0295022319254634,0.0046867735503538,-0.0386883080841568,-0.0203161557667699,3.10285232120427e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51784,0.0253057852080671,0.00431263978122967,0.0168530112368569,0.0337585591792772,4.44247614850642e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",23400,0.00287760345883334,0.00550255784594357,-0.00790740991921606,0.0136626168368827,0.601008838701519
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",23400,-0.0161675142049752,0.0149605734034531,-0.0454902380757433,0.0131552096657928,0.279852954536538
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",23400,0.00448803886314134,0.0106792671465057,-0.0164433247440098,0.0254194024702925,0.674301437044136
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",23400,0.00397425929141988,0.00651102499360142,-0.0087873496960389,0.0167358682788787,0.541609956747092
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51943,0.00669329611913026,0.00722916766317586,-0.00747587250069444,0.020862464738955,0.354515929893709
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51943,0.00600742745300682,0.00930996784799891,-0.0122401095290711,0.0242549644350847,0.518756159897267
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51943,0.00654361955030248,0.00713934728157025,-0.00744950112157521,0.0205367402221802,0.359379021619153
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51943,0.026546837311482,0.0117552171757476,0.00350661164701663,0.0495870629759474,0.0239309332921076
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51943,-0.0184780438983719,0.0284506019939354,-0.0742412238064852,0.0372851360097414,0.516032247906578
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51943,0.0182916753404883,0.0196773152853708,-0.0202758626188385,0.0568592132998151,0.352591944309293
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51943,-0.0573654927696921,0.0311156468683172,-0.118352160631594,0.00362117509220958,0.0652439338097771
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51783,-0.00287186787565493,0.00598826987496147,-0.0146088768305794,0.00886514107926955,0.631526503877108
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51783,-0.0169605937923994,0.0102343879835068,-0.0370199942400726,0.00309880665527385,0.0974818273623439
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51783,0.0142097959920997,0.00537523534402671,0.00367433471780738,0.0247452572663921,0.00820621881805947
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51783,-0.0236028457295006,0.00901979766683727,-0.0412816491565017,-0.00592404230249957,0.00887887533853236
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51783,-0.0133499602500536,0.00893284297077426,-0.0308583324727711,0.00415841197266397,0.135056151826488
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51783,-0.0124463877328917,0.00502530712383809,-0.0222959896956143,-0.00259678577016903,0.013261951339947
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,16129,-0.0299009633112194,0.0121509940493662,-0.0537169116479772,-0.00608501497446153,0.0138738153625309
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,16129,-0.0349355967877296,0.0104295905761311,-0.0553775943169467,-0.0144935992585126,0.000810960122417691
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,16129,-0.0233171713860599,0.0144563974764924,-0.051651710439985,0.00501736766786526,0.106779084021646
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,16129,0.0265989755561259,0.0115098343898907,0.00403970015194022,0.0491582509603116,0.0208466208082603
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51725,0.0178534132843346,0.0152097684776404,-0.0119577329318405,0.0476645595005098,0.240475623186489
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51725,0.00714446254360787,0.022550465933047,-0.0370544506851642,0.0513433757723799,0.751380661394365
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51725,0.0307865537224666,0.0401338772208732,-0.0478758456304449,0.109448953075378,0.443027689723739
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51725,-0.0070645076323194,0.0386860693586301,-0.0828892035752345,0.0687601883105956,0.855103850524826
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51725,0.0166906606106615,0.0132711216661035,-0.00932073785490128,0.0427020590762243,0.208517649991664
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51725,0.00457784480786364,0.0176936516366848,-0.0301017124000385,0.0392574020157658,0.795846069415705
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51725,0.0121115465685172,0.00817091590253898,-0.00390344860045921,0.0281265417374936,0.138273159658995
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",16777,0.0391853918391631,0.0131611584158741,0.0133895213440499,0.0649812623342763,0.00291166265941439
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",16777,-0.0704432053728794,0.014134245043927,-0.0981463256589763,-0.0427400850867826,6.29471858421547e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",16777,0.0151671347753667,0.0192007526739581,-0.0224663404655911,0.0528006100163244,0.42958334547818
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",16777,-0.0277814438970692,0.00675629779763719,-0.0410237875804381,-0.0145391002137003,3.94230184615872e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",23546,-0.0430300752027649,0.0063009373674559,-0.0553799124429785,-0.0306802379625513,8.74963472017055e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",23546,0.0273206595146925,0.00614960390896764,0.015267435853116,0.0393738831762691,8.92544782319531e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",23546,0.0187841503636598,0.00562153026063246,0.00776595105282015,0.0298023496744994,0.000834670270137228
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",23547,-0.0213170234766704,0.0133243893452936,-0.0474328265934459,0.00479877964010516,0.10964530114321
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",23547,-0.0286606447797117,0.00797322659727214,-0.0442881689103651,-0.0130331206490583,0.000325540887845258
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",23547,-0.00121812289821266,0.0107534575100914,-0.0222948996179917,0.0198586538215664,0.909811660030191
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51783,-0.0133642686758292,0.0125426996162608,-0.0379479599237003,0.011219422572042,0.286653893097824
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51783,-0.00824215942085314,0.00883360204919711,-0.0255560194372795,0.00907170059557319,0.350800431737021
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51783,-0.0204998935769086,0.024312951115465,-0.06815327776322,0.0271534906094028,0.399138590209251
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51783,-0.0310966813671692,0.0090588671223357,-0.0488520609269472,-0.0133413018073912,0.00059799507703298
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51783,-0.0128108656048731,0.0103190852172741,-0.0330362726307303,0.00741454142098401,0.214436694031279
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51783,-0.0669720547340988,0.0118703746821659,-0.0902379891111439,-0.0437061203570536,1.69011073291346e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51783,0.00977189342225091,0.00390304208453277,0.00212193093656669,0.0174218559079351,0.0122946343699915
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,10092,-0.0338597781271646,0.0113421560734868,-0.0560904040311988,-0.0116291522231304,0.00283977407463077
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,10092,-0.020868503276526,0.0141497965820134,-0.0486021045772722,0.00686509802422031,0.140290274423807
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,10092,0.0317598961177784,0.0100514345114384,0.0120590844753592,0.0514607077601975,0.0015837823219773
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,10092,-0.00213464284287128,0.00899342028283673,-0.0197617465972313,0.0154924609114887,0.812385396166564
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52020,-0.00747105155220596,0.00457348779850524,-0.0164350876372762,0.00149298453286432,0.102358023099898
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52020,-0.0320982296325762,0.013148566563323,-0.0578694200966893,-0.00632703916846303,0.0146420135480108
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52020,-0.000951358871891939,0.00427441617765153,-0.00932921458008894,0.00742649683630506,0.823870685647274
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52020,-0.00428267517345469,0.00413616079790138,-0.0123895503373414,0.00382419999043202,0.30047631928946
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52020,-0.0226007345001842,0.00640883452231867,-0.0351620501639288,-0.0100394188364396,0.000421458550271283
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52020,-0.00393739440540223,0.00571345520427245,-0.0151357666057762,0.00726097779497176,0.490735614126293
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52020,0.00168926771295344,0.00444614247468415,-0.0070251715374275,0.0104037069633344,0.703991448682754
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52020,-0.0469134272671011,0.0130883271256568,-0.0725665484333884,-0.0212603061008137,0.000338199771931884
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,35999,0.0204630535933457,0.00449250747940553,0.0116577389337109,0.0292683682529806,5.25749942174673e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,35999,0.00795538257568207,0.00469359762907706,-0.00124406877730896,0.0171548339286731,0.090094800165852
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,35999,-0.00584666907376464,0.0052962740647406,-0.0162273662406562,0.00453402809312693,0.26963471542929
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,36000,-0.00714978735806078,0.00724579497136756,-0.0213515455019412,0.00705197078581964,0.323771902271313
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,36000,0.00119535853411574,0.00474710799903825,-0.00810897314399923,0.0104996902122307,0.801191112791704
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51540,-0.00391106161320739,0.00460627946643782,-0.0129393693674255,0.00511724614101074,0.39584533208098
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51540,0.0124402731718797,0.00366447494838962,0.00525790227303606,0.0196226440707234,0.000687227288673282
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51540,0.00186795290599622,0.00406471900208417,-0.00609889633808875,0.00983480215008119,0.64583920017791
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51540,0.0445201808315336,0.00734632847134728,0.030121377027693,0.0589189846353743,1.36897325573607e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51575,0.0108138190140806,0.00404644932837475,0.00288277833046612,0.0187448596976952,0.00753296257508879
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51575,0.0585584374619074,0.00630818494674821,0.0461943949662809,0.0709224799575339,1.71061108973638e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51783,-0.0036346836197521,0.00398834115941622,-0.0114518322922079,0.0041824650527037,0.362127263689165
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51783,0.0122137245435118,0.00472364460680624,0.00295538111417156,0.021472067972852,0.00972206687920817
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51783,-0.0066778656310899,0.00711543160090776,-0.0206241115688691,0.0072683803066893,0.347989507855494
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51783,-0.00591077896117808,0.00904275534232479,-0.0236345794321347,0.0118130215097785,0.513341514018112
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51783,-0.00899256538775954,0.00985914857525062,-0.0283164965952508,0.0103313658197317,0.36171840511193
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51783,-0.0158949502695708,0.0117591536629512,-0.0389428914489552,0.00715299090981352,0.176474427792325
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",29455,-0.00759237983414779,0.00249202389097547,-0.0124767466604597,-0.00270801300783587,0.00231594725573701
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X864.Number of days or week walked 10+ minutes,50894,0.0418705853305849,0.0197865278076199,0.00308899082764985,0.08065217983352,0.0343397984916194
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X874.Duration of walks,44073,0.00630288113185899,0.00196270622628576,0.00245597692833889,0.0101497853353791,0.00132220729982439
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,49192,0.0678111663542949,0.0191887689175805,0.0302011792758372,0.105421153432753,0.000409853475610683
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X894.Duration of moderate activity,38080,0.0464111313477818,0.0233507287610577,0.000643702976108655,0.092178559719455,0.0468667833497471
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X90087.No-wear time bias adjusted average acceleration,10864,0.016129144243455,0.00419057467388463,0.00791561788264114,0.0243426706042689,0.000119325177589043
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,49110,0.12264243994648,0.0198039644758502,0.0838266695738132,0.161458210319146,5.95632912389581e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X914.Duration of vigorous activity,27505,0.00978858690649077,0.00246849921047469,0.00495032845396038,0.0146268453590212,7.3458390587349e-05
